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“What you do makes a difference, and you have to decide  
what kind of difference you want to make.” 
 
Jane Goodall 
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Summary 
Epigenetic mechanisms, including nuclear architecture, chromatin structure, 
chromatin dynamics and histone and DNA modifications, are fundamental players 
for correct cellular function. Chromatin organization and epigenetic signature 
distinguish pluripotent stem cells (ESC) from somatic cells. A less compacted 
chromatin structure and higher levels of histone modifications characteristic of 
euchromatin allow ES chromatin to assume a globally more open conformation 
than in differentiated cells. These chromatin properties seem to reflect a 
functionally important hallmark of pluripotency. How all of these changes occur 
during the differentiation process is yet to be elucidated. 
Clustering of heterochromatin at nucleoli is a phenomena occurring in many 
organisms, yet its physiological relevance is poorly understood. Within the 
nucleolus of somatic cells, a fraction of 400 ribosomal RNA (rRNA) genes (in 
mouse and human cells) is transcriptionally silent, possesses epigenetic features 
characteristic of constitutive heterochromatin, and is stably inherited 
independently of cell metabolic activities. Silent rRNA genes represent a striking 
example of an epigenetically regulated heterochromatic domain. So far, studies 
concerning the regulation of epigenetic rDNA silencing investigated the 
mechanisms involved in the transmission of the silent heterochromatic structure of 
the rRNA genes through cell division (maintenance of silencing). These studies 
identified the nucleolar remodelling complex NoRC as the key factor that 
establishes and maintains silent rDNA chromatin structure during cell cycle. NoRC 
function requires the association of TIP5, the major subunit of NoRC, with the 
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non-coding RNA termed pRNA, which derives from processing of a 2kb long 
intergenic spacer (IGS)-rRNA transcript. 
Here, we show that during ESC differentiation, rRNA genes acquire 
heterochromatic marks concurrently with the maturation of centric and pericentric 
heterochromatin. Impairment of intergenic-spacer (IGS)-rRNA processing in ESCs 
abrogates formation of mature pRNA and determines the lack of rDNA 
heterochromatin. Upon differentiation, pRNA is produced and enables the 
nucleolar repressor TIP5 to associate with TTF1, docking the complex to rDNA, 
an interaction inhibited by IGS-rRNA. Addition of pRNA to ESCs is sufficient to 
establish nucleolar and nuclear heterochromatin as it is found in somatic cells and 
impairs pluripotency, while depletion of TIP5 inhibits differentiation. The results 
link the epigenetic state of the nucleolus with pluripotency and commitment and 
unravel a further level of non-coding RNA (ncRNA) regulation through the ability 
of RNA processing to modulate distinct features of the same ncRNA. 
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Zusammenfassung 
Für die Funktion einer Zelle sind epigenetische Mechanismen, sowie die nukleare 
Architektur, Chromatinstruktur und -dynamik, Histon- und DNA-Modifikationen 
grundlegende Voraussetzungen. Anhand der Chromatinorganisation und 
epigenetischen Signatur können pluripotente Stammzellen (ESCs) von 
somatischen Zellen unterschieden werden. Offene Chromatinstrukturen und die 
zugehörigen Histonmodifikationen sind charakteristisch für ESCs. Im Gegensatz 
zeichnen sich differenzierte Zellen durch ein wesentlich kompakteres Chromatin 
aus. Diese Chromatin-Eigenschaften stellen vermutlich ein wichtiges Kennzeichen 
der Pluripotenz von ESCs dar. Wann und wie diese Veränderungen während des 
Differenzierungsprozesses auftreten ist bislang jedoch ungeklärt. 
Die Clusterbildung von Heterochromatin an den Nukleoli ist ein Phänomen, 
welches in vielen Organismen auftritt, und über dessen physiologische Relevanz 
nur wenig bekannt ist. In den Nukleoli von somatischen Zellen ist ein Anteil der 
ca. 400 ribosomale RNA (rRNA)-Gene (in menschlichen und murinen Zellen) 
transkriptionell inaktiv. Ihre epigenetische Eigenschaften sind charakteristisch für 
konstitutives Heterochromatin und werden stabil und unabhängig vom 
Zellmetabolismus weitervererbt. Diese stillgelegten rRNA-Gene sind ein Beispiel 
für epigenetisch regulierte heterochromatische Domänen. Bisherige Studien der 
epigenetischen Regulierung dieser rDNA-Domänen untersuchten den 
Mechanismus, der für die Vererbung von stillgelegtem Heterochromatin der rRNA-
Gene während der Zellteilung verantwortlich ist (Aufrechterhaltung der 
transkriptionellen Inaktivierung). Diese Studien identifizierten den nucleolar 
remodelling complex (NoRC) als eine Schlüsselkomponente, die die 
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transkriptionell inaktiven rDNA-Domänen im Chromatin etabliert und über den 
Zellzyklus hinaus aufrecht erhält. Die Funktion des NoRC benötigt die Assoziation 
von TIP5 mit einer nicht-kodierenden RNA, genannt pRNA, welche als Produkt 
bei der Prozessierung des 2 kb langen intergenic spacer (IGS)-rRNA Transkripts 
entsteht. 
In der vorliegen Arbeit zeigen wir, dass heterochromatische Markierungen in den 
rRNA-Genen während der ESC-Differenzierung gleichzeitig mit der Maturation 
von centromerischem und pericentromerischen Heterochromatin erworben 
werden. Die Beeinträchtigung der IGS-rRNA Prozessierung in ESCs verhindert 
die Bildung der maturen pRNA und führt zu fehlenden heterochromatischen 
Strukturen in den rRNA-Genen. Die Produktion der pRNA erfolgt während der 
Differenzierung und erlaubt die Assoziation des nukleolären Repressors TIP5 mit 
TTF1. Dadurch kann dieser Komplex an die rDNA binden, was zuvor durch die 
IGS-rRNA verhindert wurde. Alleine die Zugabe von pRNA zu ESCs ist 
ausreichend, um nukleoläres und nukleares Heterochromatin, ein typisches 
Merkmal somatischer Zellen, zu etablieren und die Pluripotenz dieser Zellen zu 
beeinträchtigen. Im Gegenzug wird die zelluläre Differenzierung in Abwesenheit 
von TIP5 inhibiert. Diese Ergebnisse weisen auf eine Verbindung des 
epigenetischen Status des Nukleolus mit der Pluripotenz einer Zelle und deren 
Bestimmung hin. Damit wird eine weitere Form der Regulation durch eine nicht-
kodierende RNA (ncRNA) entschlüsselt, die der ncRNA je nach Status der RNA-
Prozessierung verschiedene Eigenschaften verleiht. 
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Abbreviations 
2i           2 inhibitors 
5caC 5-carboxylcytosine 
5fC 5-formilcytosine 
5hmC 5-hydroxylmethycytosine 
5mC           5-methylcytosine, also known as 5meC 
ADP adenosine diphosphate 
ATP adenosine triphosphate 
BMP4 bone morphogenetic factor-4 
bp base pairs 
CGI CpG island 
CH           CHIR99021 inhibitor 
ChIP           chromatin immunoprecipitation 
DNA            deoxynucleic acid 
Dnmt DNA methyltransferase 
EB embryoid body 
EGC embryonic germ cell 
EpiESC epiblast stem cell 
ESC embryonic stem cell 
Fgf4 fibroblast growth factor 4 
GSK3 glucogen synthase kinase-3 
GST glutathione S-transferase 
His histidine 
HMG high mobility group 
HMT histone methyltransferase 
HKMT histone lysine methyltransferase 
HP1 heterochromatin protein 1 
ICM inner cell mass 
IGS intergenic spacer  
IGS-rRNA intergenic spacer rRNA 
iPSC induced pluripotent stem cell 
Abbreviations 
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JAK Janus kinase 
JMJD2 lysine-specific demethylase 4A 
K, Lys lysine 
kb kilobases 
kDa kilodalton 
LAD lamina associated domain 
LIF leukemia inhibitory factor 
LIFR leukemia inhibitory factor receptor 
lncRNA long non-coding RNA 
LOCK large organized chromatin domains 
LSD1 lysine-specific demethylase 
MAPK mitogen activated protein kinase 
MBP methyl-CpG-binding protein 
MEF mouse embryionic fibroblast 
MNase micrococcal nuclease 
mRNA messenger ribonucleic acid 
ncRNA non-coding RNA 
NOR nucleolar organizing region 
NoRC nucleolar remodeling complex 
NPC neural progenitor cell 
nt nucleotide 
NT nuclear transplantation, also known as SCNT 
PARP poly(ADP-ribose)polymerase 
PcG polycomb group 
PD PD0325901 inhibitor 
PGS primordial germ cell 
PHD plant homeodomain 
PI3K phosphoinositide 3 kinase 
Pol  RNA polymerase  
pre-rRNA precursor ribosomal RNA 
pRNA promoter RNA 
PTMs posttranslational modifications 
Abbreviations 
 
 
 
7 
R, Arg arginine 
rDNA ribosomal DNA 
RENT regulator of nucleolar silencing and telophase exit 
RNA ribonucleic acid 
rRNA ribosomal RNA 
qRT-PCR quantitative real time PCR 
RT-PCR reverse transcription polymerase chain reaction 
SAM S-adenosylmethionine 
SCNT somatic cell nuclear transfer, also known as NT 
SHP2 SH2 domain containing tyrosine phosphatase 2 
SL1 selectivity factor 1 
Snf2h sucrose non-fermenting protein 2 homologue 
Stat3 signal transducer and activator of transcription 3 
TAFI TBT-associated factor 
TBT TATA box binding protein 
TDG thymidine DNA glycosylase 
TET ten-eleven-translocation 
TF transcription factor 
TGF-b transforming growth factor beta 
TIF-IA transcription initiation factor-IA 
TIF-IB  transcription initiation factor-IB 
TIP5 TTF-I interacting protein 5  
TrxG trithorax 
TSP, T0, T1-10 terminator elements 
TSS transcription start site 
TTF-I  transcription termination factor 
UBF upstream binding factor 
UCE upstream control element 
ZF zinc finger 
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1 Introduction 
1.1 Chromatin structure  
Efficient packaging of genomic DNA in eukaryotes is allowed by organization in 
DNA-protein complexes, termed chromatin (Lodish, 2013). The packaging of DNA 
into chromatin is critical both for the physical compaction of the genome into the 
nucleus and as a mean to regulate access to the genetic material for DNA-based 
transactions, such as transcription, replication, and repair. The basic unit of the 
chromatin is the nucleosome, which consists of 147 bp of DNA wound around the 
surface of an octamer of two copies each of four core histone proteins H2A, H2B, 
H3 and H42. Adjacent nucleosomes are connected by the linker histone H1 bound 
to variable length of linker DNA (10-100 bp) forming a bead-on-a-string-like 
structure (Felsenfeld and Groudine, 2003; Wolffe, 1997). Further diversification of 
nucleosome core particles is obtained by varying amino acid sequence of 
histones, leading to a set of histone isoforms known as histone variants. In some 
cases, the histone variants can alter the architecture of the histone octamer, and 
as a consequence, of the chromatin structure (reviewed in (Sarma K, 2005)). 
Beyond the nucleosome, chromatin folds into successively higher-order structures 
that remain poorly described at a molecular level. 
Several mechanisms have been described to dynamically alter the nucleosome 
spacing and accessibility: ATP-dependent chromatin remodelers, DNA 
methylation, histone modifications and incorporation of specific histone variants.  
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1.1.1 Histone modifications 
The pioneering studies in the early 1960s have shown that histones are bearing 
posttranslational modifications (PTMs) (Allfrey et al., 1964). The core histone 
proteins are predominantly globular except for their unstructured N-terminal tails, 
which extend away from the globular core. Importantly, these histone tails posses 
a large number and different types of modified residues. These enzyme-catalyzed 
covalent modifications include acetylation, methylation, phosphorylation, 
ubiquitynation, sumoylation, ADP-ribosylation, deimination, β-N-
acetylglucosamination, histone tail clipping and proline isomerization (reviewed in 
(Bannister and Kouzarides, 2011)).  Since most of the histone modifications are 
reversible, this marking system represents a fundamental regulatory mechanism 
for chromatin function (Jenuwein and Allis, 2001). Modifications not only regulate 
higher-order chromatin structure by affecting inter-nucleosomal interactions, but 
they recruit effector proteins and complexes with specific enzymatic activities such 
as remodeling enzymes that utilize the energy derived from the hydrolysis of ATP 
to reposition nucleosomes (Strahl and Allis, 2000).  
 
Each histone tail within the nucleosome is characterized by multiple 
posttranslational modifications, which is creating a distinct chromatin signature. 
Histone modifications are occurring in a variety of different combinations, of which 
each affects gene transcription and chromatin structure. This combinatory 
occurrence of histone modification led to the concept of the histone code 
(Jenuwein and Allis, 2001; Strahl and Allis, 2000).  The histone code extends the 
information given by genetic code and together with DNA methylation and 
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nucleosome remodeling processes and their cognate regulatory proteins is 
classified under the general term “epigenetic mechanisms”. 
1.1.1.1 Histone Methylation 
Methylation of histone residues can mediate both active and repressive signals, 
which regulate gene transcription through recruitment of specific downstream 
effector proteins. 
Histone methylation mainly occurs on the side chains of lysines (Lys, K) and 
arginines (Arg, R), in the N-terminal tails of histone H3 and H4 as well as in the 
glogular domain of histones. Histone methylation is performed by histone 
methyltransferases (HMTs) which catalyze the transfer of a methyl group from S-
adenosylmethionine (Tsai et al.) to a lysine or arginine residue.  All known histone 
methyltransferases contain a conserved methyltransferase domain termed SET 
(Su(var)3-9, Enhancer-of-zeste, Tritorax) (Lachner and Jenuwein, 2002). 
 
Histone lysine methyltransferase (HKMT) possess a high level of substrate 
specificity with respect to their target lysine and also modify the appropriate lysine 
to a specific degree (i.e., mono-, di- and/or tri-methyl state). For example, the 
methylation pattern of histone 3 lysine 9 (H3K9) is established by different HMTs; 
G9a and GLP, which exist predominantly as a G9a-GLP heteromeric complex, are 
the primary mono- and di-methylases (H3K9me1 and H3K9me2), whereas 
SUV39H2 di- and tri-methylates a mono-methylated substrate. Tri-methylation of 
lysine 9 of histone 3 (H3K9me3) represents a specific mark for epigenetic 
transcriptional repression that is specifically recognized by heterochromatin 
protein 1 (HP1) and is linked to heterochromatin condensation and gene silencing 
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(Bannister et al., 2001; Lachner et al., 2001). Another important example of 
specific histone lysine methyltransferase activity are the trithorax (TrxG) and 
Polycomb (PcG) multiprotein complexes which contain histone 
methyltransferases. TrxG and PcG have reciprocal functions: TrxG proteins work 
together to activate transcription while PcG proteins repress transcription 
(reviewed in (Muller and Verrijzer, 2009)). TrxG histone modifiers, TRX and ASH1 
methylate histone H3 lysine 4 (H3K4) active mark (Strahl and Allis, 2000). PcG 
complexes are made up of polycomb repressive complex 2 (PRC2) and polycomb 
repressive complex 1 (PRC1). PRC2 (EHZ2) complex deposits the H3K27me3 
inactive chromatin mark while PRC1 interprets this code(Levine et al., 2004). The 
regulatory effects of PcG and TrxG are broad and are mediated through various 
histone modifications and nucleosome remodelling. Some of the specific 
examples in embryonic stem cells are discussed in Chapter 1.2.3. 
 
Recently, the search for enzymes for reversal reaction to lysine methylation 
identified lysine-specific demethylase 1 (LSD1) compatible with mono- and 
dimethylated lysine substrates which is in different complexes able to demethylate 
H3K4me1/2 and H3K9me2 (Shi et al., 2004). The first enzyme identified as a tri-
methyl lysine demethylase was JMJD2 (lysine-specific demethylase 4, also known 
as KDM4) that demethylates H3K9me3 and H3K36me3 (Whetstine et al., 2006). 
1.1.2 DNA methylation 
Like histone methylation, DNA methylation also plays a role in regulating gene 
expression of cells. DNA methylation is highly conserved epigenetic modification 
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of DNA, which occurs on the cytosine base of the DNA within CpG dinucleotides 
in prokyriotes as well as in eukaryotes. The most of vertebrate genome contains 
few CpG dinucleotides and they tend to be converted to 5-methylcytosines (5mC). 
Unmethylated CpGs are very offten found locally very dense, organized in 
clusters called CpG islands (CGIs). DNA methylation is generally considered as a 
mark of silent, inactive chromatin and is inversely correlated with gene activity, 
although this association is dependent on CpG density. CpG-rich promoters  are 
associated with ubiquitously expresses “housekeeping” genes and with regulatory 
genes expressed during development. In contrast, CpG-poor promoters are 
generally associated with tissue-specific genes. 
 
DNA methylation is carried out by DNA methyltransferases (DNMTs) catalyzing 
the transfer of methyl group from S-adenosyl-methionine (Tsai et al.) to CpG 
dinucleotides of genomic DNA (Jeltsch, 2006).  
Methylation patterns are established de novo during embryonic development and 
stably inherited upon cell divisions. The maintenance of DNA methylation during 
replication depends on DNMT1, which attaches a methyl group to hemimetylated 
DNA. The de novo establishment of DNA methylation is performed by DNMT3A 
and DNMT3B, which are able to act on hemimethylated and unmethylated CpG-
dinucleotides. The role of DNMTs in embryonic stem (ES) cells has been 
analyzed using homozygous mutants. Inactivation of genes encoding DNMT3A 
and DNMT3B blocks de novo methylation in ES cells and mouse embryos. These 
methyltransferases are required for normal mammalian development but have no 
influence on the maintenance of imprinted methylation patterns (Okano et al., 
1999). In mouse development, mutation of Dnmt1 gene results in embryonic 
1 Introduction 
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lethality (Li et al., 1992). Moreover, DNMT1-/-  ES cells divide and maintain 
pluripotency in culture, but show elevated mutation rates and fail to survive after 
being induced to differentiate (Chen et al., 1998; Jackson et al., 2004). These and 
other studies have shown the importance of DNA methylation for maintaining 
genome stability, the establishment and the maintenance of stable cellular 
identities, transposable element silencing, genomic imprinting and X chromosome 
inactivation (reviewed in (Wu and Zhang, 2010b)).  
 
The effect of DNA methylation on gene expression may be direct or indirect. 
Some DNA binding proteins (e.g. transcription factors) are only able to interact 
with their target sequence if unmethylated (Clark et al., 1997), whereas CpG 
methylation directly abolishes their interaction with DNA and leads to lower 
transcription level. On the other hand, methylated DNA can be specifically 
recognized by a set of proteins called methyl-CpG-binding proteins (MBPs), which 
belong to three different structural families in mammals: the MBD family, the Kaiso 
and Kaiso-like proteins and the SRA domain proteins.  These proteins were 
shown to associate and recruit chromatin repressor factors such as histone 
deacetylases, thus establishing silent chromatin at methylated CpG sequences 
(Defossez and Stancheva, 2011). 
Compared with other epigenetic modifications, DNA methylation is thought to be 
relatively stable (Wu and Zhang, 2010a). However, studies in the past decade 
have revealed that this modification is not as static as once thought. Loss of DNA 
methylation can occur through a passive or an active process. Active DNA 
demethylation is the enzymatic process that results in the removal of the methyl 
group from 5-methylcytosine (5meC) by breaking a carbon-carbon bond. By 
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contrast, passive DNA demethylation refers to the loss of the methyl group from 
5meC when DNMT1 is inhibited or absent during successive rounds of DNA 
replication. Examples of both processes can be found at early development 
where, after fertilization, the paternal genome rapidly undergoes genome-wide 
active demethylation and remains as such in the consecutive rounds of cells 
divisions. In contrast, the maternal genome experiences gradual, passive 
demethylation. The three mammalian TET (ten-eleven-translocation) family 
proteins, namely TET1, TET2 and TET3, are dioxygenaze that successively 
oxidize DNA 5-methylcytosine to 5-hydroxymethylcytosine (5hmC), 5-
formilcytosine (5fC) and 5-carboxylcytosine (5caC). All three forms of oxidized 
methylcytosine are known to be present in numerous mammalian tissues. 5hmC 
has been found present as 5-10% of 5mC level in embryonic stem cells and even 
higher in neurons. 5fC and 5caC are present at much lower levels than 5hmC, 
0.03% and 0.01%, respectively, of the level of 5mC in ESCs. These low levels can 
at least partially be explained by their enzymatic removal by thymidine DNA 
glycosylase (TDG) base excision repair and possibly decarboxylation by yet 
unknown enzymes (reviewed in (Pastor et al., 2013)). 
1.1.3 Euchromatin and heterochromatin  
More than a century ago, distinct chromatin regions were observed within the 
genome by staining with basic dyes. The barely visible regions, termed 
euchromatin decondense during interphase whereas the strongly stained 
heterochromatin remains constantly stained throughout the cell cycle (reviewed in 
(Fransz et al., 2003)). Euchromatin and heterochromatin represent not only 
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structural types, but also main functional states of chromatin. Euchromatin is gene 
rich, contains irregular nucleosomal array and it is easily accessible by 
transcription factors. On the contrary, heterochromatic genome regions are gene 
poor, late-replicating and highly condensed which tends to be refractory for 
transcription. The heterochromatin is further subdivided in two types, facultative 
and constitutive (reviewed in (Dillon and Festenstein, 2002)).  Facultative 
heterochromatin is characterized mainly by high levels of H3K27me3 (Cao et al., 
2002), and the related PRC1-catalysed ubiquitination of H2AK119 (Grewal and 
Elgin, 2007). Constitutive heterochromatin is strongly enriched in H3K9me3, 
H4K20me3 and H3K64me3, as well as in DNA methylation (Daujat et al., 2009; 
Peters et al., 2001; Schotta et al., 2004), but deprived of histone acetylation and is 
mainly found at centromeric, pericentromeric, and telomeric regions. 
Heterochromatic regions often clusters together, whereas the more open 
euchromatic regions are dispersed in the nucleoplasm or underlie nuclear pores 
(Meister and Taddei, 2013). Remarkably, heterochromatic clusters are not 
randomly distributed within the nucleus, but are enriched at the nuclear periphery 
and around the nucleolus (Gonzalez-Sandoval et al., 2013). This suggests that 
the spatial distribution of heterochromatin may be regulated, and could, in turn, 
influence chromatin-based functions. In support of this, nuclei of different tissues 
have distinct and recognizable distributions of euchromatin and heterochromatin 
(Solovei et al., 2013). Generally, inactive genes are sequestered in a tissue-
specific manner at the nuclear periphery of differentiated cells, whereas activated, 
developmentally controlled promoters are sequestered in the nuclear center. This 
has recently been documented for genes of three distinct tissue types in 
Caenorhabditis elegans, and has been shown for a number of loci during 
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mammalian hematopoietic differentiation (Hubner et al., 2013; Meister et al., 
2010). These observations, together with the fact that changes in heterochromatin 
organization are widely used as clinical markers of neoplastic transformation (Zink 
et al., 2004), argue that chromatin within the nucleus has an intrinsic and 
potentially useful order (Gonzalez-Sandoval et al., 2013). 
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1.2  Embryonic stem cells 
Embryonic stem cells (ESCs) derive from the inner cell mass (ICM) of a 
blastocyst, an early-stage preimplantation embryo (in mouse, E3.5). They are 
characterized by their potential to self-renew indefinitely and to differentiate into 
any of the three germ layers: endoderm, mesoderm and ectoderm. These 
attributes that define the pluripotency state render ESC particularly attractive as 
models to study early developmental decision-making (commitment) as well as its 
execution (differentiation). Only cells in the zygote have a greater lineage potential 
than ESCs, defined as totipotent, being able also to generate extra-embryonic 
tissues including trophectoderm (Fisher and Fisher, 2011). 
 
Self-renewal is the process by which stem cells divide to make more stem cells, 
perpetuating the stem cell pool throughout life. Self-renewal is division with 
maintenance of the undifferentiated state. In this process, a stem cell divides 
asymmetrically or symmetrically to generate one or two daughter stem cells that 
have a developmental potential similar to the mother cell. Symmetric division 
generates two identical sister cells whereas during asymmetric division one cell 
preserves the original phenotype of the mother cell and the second cell acquires a 
new phenotype. Asymmetric division is the basic mechanism for maintaining cell 
diversity, but both types of cell division ensure that physiological and 
morphological properties of the parental cells are transmitted to the next cell 
generation. The ability to self-renew is essential for stem cells (embryonic and 
adult) to expand their number during development, to be maintained within adult 
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tissues, and to restore the stem cell pool after injury. Defects in self-renewal 
mechanisms can lead to developmental defects, premature aging phenotypes, 
and cancer (reviewed in (He et al., 2009)).   
 
The self-renewal and pluripotency features of ESCs make them an ideal in vitro 
tool to study early mammalian development, but it also offers great therapeutic 
potential within the field of regenerative medicine. As ESCs might represent a 
potential source for cell and tissue replacement, the molecular and cellular 
mechanisms controlling pluripotency and differentiation have to be elucidated in 
order to make these potential clinical applications a reality.  
 
ESCs were successfully derived by explanting blastocysts or ICMs on a layer of 
“feeder” cells (mitotically inactivated fibroblasts) in medium containing fetal calf 
serum (Evans and Kaufman, 1981; Martin, 1981). Evans and Kaufman facilitated 
the derivation of ESCs by using the embryonic diapose property of rodents. 
Diapause is a condition of embryo arrest at the peri-implantation blastocyst stage, 
where implantation is prevented by estrogen deprivation. The derivation of mouse 
ESCs using feeders and serum is inefficient and variable and the genetic 
background has a major influence on the capacity to give rise to ESCs. For many 
years, the ESC derivation was poorly understood and it became necessary to 
refine the culture conditions and define the molecular requirements for efficient 
generation of ECSs. In 1988, two different studies by Williams and Smith found 
that the self-renewal support coming from feeder cells arose from cytokine 
produced by these cells termed leukemia inhibitory factor (LIF) (Smith et al., 1988; 
Williams et al., 1988). LIF promotes ESC self-renewal by activation of the 
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transcription factor Stat3 (Matsuda et al., 1999; Niwa et al., 2000). Lately, serum 
has been replaced by addition of bone morphogenetic factor-4 (BMP4) (Ying et 
al., 2003). 
 
In 1999, Burdon and colleagues showed that the inhibition of the Erk pathway 
(also called mitogen activated protein kinase, MAPK) promoted self-renewal of 
ESCs by blocking differentiation cues provided by it (Burdon et al., 1999). 
Inhibition of another enzyme, glycogen synthase kinase-3 (GSK3), was also 
shown to enhance ESC self-renewal (Sato et al., 2004). Recent developments 
have enabled the derivation of ESCs in defined serum-free medium supplemented 
with two small-molecule kinase inhibitors (2i) (Ying et al., 2008): PD0325901 
blocks differentiation via the MAP kinase pathway and CHIR99021 enhances self-
renewal of ESCs by activating Wnt signaling (Wray et al., 2010; Ying et al., 2008). 
ESCs grown in 2i are more homogeneous in morphology and gene expression 
than serum ESCs, and are postulated to represent the ground state of 
pluripotency (reviewed in (Marks and Stunnenberg, 2014)). Recent studies have 
shown that the epigenome and transcriptome of 2i and serum ESCs are markedly 
different, suggesting that these ESCs represent two distinct states of pluripotency 
regulated by different factors and pathways. There is growing evidence that the 2i 
ESCs closely parallel the early blastocyst cells of the inner cell mass (ICM) or 
even earlier stages, while serum cells possibly reflect later stages. 
Successful derivations have also been reported from morulae and even from 
isolated eight-cell stage blastomeres, leading to the suggestion that ESCs might 
represent a very early stage of development (Tesar et al., 2007). Embryo derived 
stem cells can be derived from pre- and early post-implantation stages of an 
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embryo. Pluripotent stem cells generated from postimplantation epiblast (E5.5-
6.5) are called epiblast stem cells (EpiSCs). These can generate 
teratocarcinomas but do not contribute effectively to blastocyst chimeras (Hayashi 
et al., 2011). Embryonic germ (EG) cells are pluripotent stem cells derived from 
primordial germ cells (PGCs) from early somite-stage embryos (E7.5-13.5) 
(Matsui et al., 1992). Once established, EG cells are indistinguishable from ESCs 
apart from a variable degree of imprint erasure. Similar to primordial germ cells, it 
is possible to convert spermatogonial stem cells into pluripotent stem cells by 
exposing them to an appropriate regime of in vitro stimuli (Kanatsu-Shinohara et 
al., 2004) (reviewed in (Nichols and Smith, 2012)). 
 
Somatic cells can acquire the ESC properties trough nuclear reprogramming. 
Over the last two decades, there have been several approaches towards efficient 
and successful reprogramming. Nuclear transplantation (NT), also referred to as 
somatic cell nuclear transfer (SCNT), denotes the introduction of a nucleus from a 
donor somatic cell into an enucleated oocyte (Wilmut et al., 1997). NT 
demonstrated that the epigenetic state of terminally differentiated cells is not 
irreversibly fixed but can be reprogrammed to a pluripotent state that is capable of 
directing development of a new organism. Another approach of epigenetic 
reprogramming of somatic nuclei to an undifferentiated state has been 
demonstrated by fusion of embryonic cells with somatic cells. This method 
indicated that the pluripotent phenotype is dominant in such fusion products since 
hybrids between various somatic and embryonic cells shared many features with 
the parental embryonic cells (Zwaka and Thomson, 2005).   
In 2006, Takahashi and Yamanaka achieved a significant breakthrough in 
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reprogramming somatic cells back to an ES-like state when they successfully 
reprogrammed mouse embryonic fibroblasts (MEFs) and adult fibroblasts to 
pluripotent ES-like cells after the forced expression of only four transcription 
factors Oct4, Sox2, c-Myc, and Klf4 (Takahashi and Yamanaka, 2006). 
Successful generation of pluripotent cells, named induced pluripotent stem cells 
(iPSC), using this technology has opened the doors to the disease modeling 
strategies and cell transplantation studies. iPSC have drawn special attention to 
both the public and scientific community because they avoid the handling of 
embryonic material and can be patient tailored (reviewed in (Liang and Zhang, 
2013)). 
 
The progression of pluripotent or undifferentiated ES cells to a differentiated 
phenotype is regulated by changes in gene expression, in which, genes that are 
responsible for self-renewal are down-regulated while lineage-specific genes are 
up-regulated. The mechanisms by which ES cells maintain their pluripotency are 
thought to be orchestrated by several crucial factors: extracellular signaling, 
transcription factor networks and epigenetic factors. 
1.2.1 Extracellular signaling in pluripotency and self-renewal 
Several key extracellular signaling pathways have been identified to be crucial in 
maintenance of pluripotency and self-renewal of ES cells. The extracellular 
signaling cascades are known to regulate ES cell pluripotency via two different 
mechanisms: targeting core pluripotency transcription factors and targeting cell 
cycle progression - related genes. Leukemia inhibitory factor (LIF), a member of 
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the IL6 family, binds to leukemia inhibitory factor receptor (LIFR) that 
subsequently heterodimerizes with gp130 receptor forming a trimeric complex, 
which triggers three different signaling pathways: the JAK (Janus Kinase)/STAT3 
(signal transducer and activator of transcription 3), the PI3K (phosphoinositide 3 
kinase)/AKT pathway and SHP2 (SH2 domain containing tyrosine phosphatase 
2)/MAPK (mitogen activated protein kinase) pathway. These three pathways 
influence self-renewal, propagation and differentiation, respectively (reviewed in 
(Burdon, 2002)). Other important signaling cascades involved in ES cells are 
Wnt/b-catenin signaling, bone morphogenic protein (BMP) signaling, fibroblast 
growth factor 4 (Fgf4) signaling and TGF-b/Activin signaling. 
1.2.2 Transcriptional network to maintain pluripotency 
A unique network of inter-related transcription factors characterizes the ESC 
state.  Indeed, a large scale RNAi mediated knockdown study identified 8 genes 
that are crucial for maintaining the undifferentiated state of ES cells, of which 7 
are transcription factors or chromatin associated proteins: Oct4, Nanog, Sox2, 
Tbx3, Esrrb, Tcl1 and Dppa4 (Ivanova et al., 2006).  
Oct4 is one of the key components of the molecular circuitry regulating embryonic 
stem cell proliferation and differentiation. Oct4 (encoded by the Pou5f1 gene) 
belongs to the Pit-Oct-Unc (POU) family of transcription factors that have two 
DNA binding domains. During mouse embryo development Oct4 is exclusively 
expressed within the totipotent mouse blastomeres, pluripotent epiblast as well as 
primodial germ cells (PGCs) (Rosner et al., 1990; Scholer et al., 1990). Sox2 is a 
member of high mobility group (HMG) box DNA binding domain proteins. It is 
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expressed within the ICM and extraembryonic ectoderm of pre-implantation 
blastocysts (Avilion et al., 2003). Importantly, both proteins have critical roles in 
the establishment and maintenance of pluripotency, as Pou5f1- and Sox2-null 
embryos do not form a pluripotent ICM, but rather, differentiate into 
trophectodermal tissue (Avilion et al., 2003; Masui et al., 2007). This similarity of 
phenotypes produced by Sox2 and Oct4 loss is attributed to the synergistic action 
of Oct4/Sox2 in the regulation of various ESC-specific genes, including 
themselves. Nanog, the third member of the core ESC transcription factors, 
sustains mESC self-renewal in the absence of leukemia inhibitor factor (LIF) 
(Mitsui et al., 2003; Wang et al., 2006). Since nanog-null pre-implantation 
embryos do not possess a pluripotent ICM, it is believed to be necessary the 
acquisition of pluripotency (Mitsui et al., 2003; Silva et al., 2009). Nanog-null 
mESCs are pluripotent, although prone to differentiation, making Nanog 
dispensable once pluripotency is achieved (Chambers et al., 2007; Mitsui et al., 
2003) (reviewed in (Yeo and Ng, 2013)).  
 
The accurate regulation of these TFs is crucial, as their over or under-expression 
would affect ES cell identity and differentiation state. Studies mapping genomic-
binding sites of these core ESC factors revealed extensive Oct4, Sox2 and Nanog 
cobinding at their own promoters, at numerous active, as well as silent genomic 
target sites (Loh et al., 2006). It was proposed that the core ESC transcription 
factors serve to establish a pluripotent state by, on one side, activating the 
expression of other pluripotency-associated factors while simultaneously 
repressing lineage-specific genes, and on the other side, by activating their own 
gene expression and that of each other in an interconnected auto-regulatory loop 
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(reviewed in (Young, 2011)). Importantly, this model may account for how ESCs 
can sustain pluripotency, while remaining poised for differentiation.  
1.2.3 Chromatin organization and epigenetic factors in pluripotency 
Studies of gene regulation in pluripotency and self-renewal initially focused on TF 
network regulation, until the importance of epigenetic and chromatin mediated 
mechanisms has been highlighted in ESC pluripotency, differentiation and early 
development (Reik, 2007).  
 
The chromatin of pluripotent stem cells is believed to have unique characteristics, 
including elevated transcription, an open conformation and a hyperdynamic 
association of chromatin proteins, reflecting the plasticity of the genome in 
pluripotent cells (Meshorer and Misteli, 2006) and likely contributing to the 
maintenance of pluripotency and self-renewal (Jorgensen et al., 2007; Meshorer 
et al., 2006). The global levels of nascent RNA and mRNA were reported to be 
almost two-fold higher in ESC than in their differentiated counterparts. 
Undifferentiated cells transcribe repetitive elements that are normally silenced in 
somatic cells and intergenic regions, whereas tissue-specific genes are 
transcribed at very low levels (Efroni et al., 2008). Many of the transcripts residing 
from intronic or intergenic regions may act as noncoding RNAs that regulate 
pluripotency (reviewed in (Mattout and Meshorer, 2010b)).   
The majority of ESC chromatin is homogeneously dispersed and largely devoid of 
condensed regions, whereas in differentiated cells chromatin appears 
heterogeneous with distinct blocks of compaction (Efroni et al., 2008). 
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Undifferentiated ESCs contain less heterochromatic regions with some chromatin 
structural proteins (e.g. Heterochromatin protein 1 HP1, histones H2A and H3) 
binding less tightly compared to lineage-committed cells (Jorgensen et al., 2007). 
General transcription factors and chromatin remodelling proteins are 
overexpressed in ESCs compared to ESC-derived lineage- restricted neural 
progenitors (NPs) (Meshorer et al., 2006). ESC chromatin is transcriptionally 
permissive, with low-level stochastic transcription of lineage-restricted genes and 
normally silent DNA repeat regions, increased nuclease sensitivity, and an 
abundance of histone modifications associated with transcription (e.g. H3K9ac, 
H3K4me3, H3K36me3). Knockdown of the chromatin remodeler Chd1 in mouse 
ESCs causes heterochromatin accumulation and skewed differentiation, 
suggesting that the ‘open’ chromatin structure of ESCs is functionally relevant 
(Gaspar-Maia et al., 2009).  
The genome of early blastocyst cells of the ICM E3.5 is hyopmethylated with 
average of CpG methylation levels of ~20%, and only a few days later (E6.5), the 
genome methylation increases with average levels reaching ~70%. A high 
similarity has been reported between the hypomethylated E3.5 blastocyst cells 
and 2i ground state ESCs, whereas serum ESCs resemble hypermethylated E6.5 
blastocyst cells (Habibi et al., 2013). During neural induction, several hundred 
genes, including stem cell specific genes, acquire CpG methylation and become 
transcriptionally silenced. The observation that most DNA methylation is acquired 
by ESC-derived neural precursors rather than upon subsequent differentiation to 
terminal neurons, suggests that changes occur in the transition from pluripotent to 
lineage-committed progenitors, a concept echoed by studies of adult stem cells 
(reviewed in (Fisher and Fisher, 2011)). Together, these results paint a broad 
1 Introduction 
 
 
 
28 
picture of chromatin in pluripotent ESCs that is open, transcriptionally permissive 
and hyperdynamic, with progression to a more compact and transcriptionally 
repressed state. 
Alterations in chromatin organization within the nucleus may also be relevant for 
gene regulation during differentiation. Using the DamID technique, sequence 
scale genomic contacts with the nuclear lamina at the periphery (termed LADS) 
have been mapped in ESCs and differentiated cells (Peric-Hupkes et al., 2010).  
LADS tend to be gene-poor but contain minimally expressed genes within regions 
marked by the repressive histone modifications H3K9me2 and H3K27me3. 
Differentiation of mouse ESCs to multipotent neural progenitors (NPs) then to 
terminal astrocytes revealed many regions undergo cell type specific relocations, 
and these movements appear to be orchestrated in a stepwise fashion. 
Pluripotency genes including Oct4  and Nanog  move to the nuclear lamina and 
are silenced while neural-lineage specific genes disassociate from the lamina and 
are induced. Genome-wide ChIP analyses have described large organised 
chromatin domains of H3K9me2 (termed LOCKS) that increase in size and 
abundance (from 4% to at most 46% genome coverage) from ESCs to 
differentiated cells (Wen et al., 2009). LOCKS show tissue-specific distributions 
and inversely correlate with gene expression, suggestive of a ‘locking-down’ of 
transcription from unneeded genomic regions.  
Two of the main residents of constitutive heterochromatin are the major and minor 
satellite repeat sequences, which are commonly methylated and located in 
centromeric regions of the genome. Major satellite repeats seem to localize 
diffusely in ESC nuclei and form well-defined chromocenters in NPCs (Meshorer 
et al., 2006).  Interestingly, major and minor satellite repeats, as well as other 
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repetitive sequences, which are normally repressed in differentiated cells, are 
highly transcribed in mouse ESCs and become associated with heterochromatin-
related histone modifications after differentiation (reviewed in (Mattout and 
Meshorer, 2010a)). Along the same lines, telomeric chromatin is associated with 
increasing levels of H3K9me3 and H4K20me3 and reduced sensitivity to 
micrococcal nuclease (MNase) digestion during ESC differentiation (Wong et al., 
2009). These studies indicate that chromatin organization is profoundly different in 
ESCs, and that this apparent open configuration may lead to transcriptional 
activity of heterochromatin domains. 
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Figure 1. A schematic view of chromatin and genome characteristics in ESCs and in 
early differentiation. (a) Chromatin protein dynamics. Chromatin proteins such as the linker 
histone H1 and core histones are more dynamically associated with chromatin in ESCs than 
in differentiated cells. HP1a and lamin B nuclear proteins also bind more loosely in pluripotent 
cells. Lamin A expression and localization in the nuclear lamina occur during early 
differentiation. (b) DNA methylation. In mammalian somatic cells, DNA methylation is present 
on cytosines in a CpG context. In pluripotent ESCs, 25% of the cytosine methylation sites in 
the genome are found in a non-CpG context, suggesting that ESCs utilize a unique DNA 
methylation program. (c) Histone modifications. The global levels of several histone 
modifications differ between ESCs and differentiated cells. This includes several active marks 
which are more abundant in ESCs, and repressive marks which are enriched in differentiated 
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cells, and which accumulate in well-defined foci (H3K9me3). Bivalent marks (H3K4me3 
together with H3K27me3) are found on promoters of developmentally regulated genes in 
ESCs, some of which resolve into a single modification in differentiated cells. (d) Centromeric 
heterochromatin. Major and minor satellite DNA repeats which are normally found at the 
heterochromatic centric and pericentric regions, are dispersed in ESCs, but form dense foci 
upon differentiation. Accordingly, centromeres are redistributed next to nucleoli and the 
nuclear periphery in differentiated cells. The inactive X chromosome in female somatic cells 
which is represented in the scheme is also repositioned next to the nuclear envelope. 
Telomeric chromatin is apparently not displaced in the nucleus, but in ESCs it has a more 
open structure. Adapted from (Mattout and Meshorer, 2010) 
 
 
Two key histone modifications that are heavily involved in ESC regulation are 
H3K4me3 and H3K27me3, which are typically associated with active and 
repressive chromatin regions, respectively. A major discovery in ESC biology was 
the co-occupancy of both H3K4me3 and H3K27me3 on large number of promoter 
sequences (Bernstein et al., 2006; Mikkelsen et al., 2007). These regions are 
named “bivalent” domains and are thought to silence developmental regulatory 
genes and prevent premature differentiation by keeping genes in a poised state, 
ready to be either transcribed or repressed. Upon differentiation, most of the 
bivalent patterns of histone modification are erased to induce activation of specific 
lineage developmental genes (retaining of H3K4 methylation) and release of the 
H3K27me3 repressive mark (reviewed in (Gaspar-Maia et al., 2011)).  
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1.3 The nucleolus 
The most prominent substructure within the nucleus is the nucleolus (from Latin, 
diminutive of nucleus). Although of small size, the nucleolus is a very productive 
compartment where ribosome biogenesis takes place. This process includes 
transcription of hundreds ribosomal RNA (rRNA) genes, rRNA processing, and 
ribosome subunit assembly. To meet the enormous demand for proteins, growing 
cells have as many as ten million ribosomes and the nucleolus must have 
sufficient capacity to fulfill the need for large-scale production of ribosomes at a 
rapid pace (Olson, 2011). Because of this enormous task, in the past 40-50 years, 
the major aim of research was to define the components and key steps in the 
ribosome synthesis and it was not suspected that the nucleolus could do much 
else. Consequently, the nucleolus managed to keep its other functions undercover 
for a while (Guetg and Santoro, 2012).  
1.3.1 Ribosomal RNA (rRNA) genes 
In eukaryotic cells, the most active site of gene transcription is the nucleolus. To 
produce an elevated number of ribosomes, cells evolved a unique and efficient 
transcription system by using a specific and efficient RNA polymerase (RNA 
polymerase I, Pol I) and by amplifying the number of rRNA genes to hundreds or 
even thousands of copies per genome (Santoro, 2011). Consequently, the 
presence of many rRNA genes transcribing at high rate has the ability to fulfil the 
requirement to generate an elevated number of rRNA moieties to meet the 
enormous demand of ribosome production.  
The nucleolus results from the fusion of several nucleolar organizing regions 
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(Morin et al.), which consist of tandemly repeated ribosomal RNA genes 
(reviewed in(Santoro, 2005)). In human, the 200 rDNA copies are located in a 
non-uniform manner between the short arm and the satellite body of the five 
acrocentric chromosomes 13, 14, 15, 21 and 26, in a telomere-to-centromer 
orientation (Henderson et al., 1972). In mouse, rDNA repeats are within the 
centromeric regions of chromosome 12, 15, 16, 18 and 19 (Dev et al., 1977; 
Henderson et al., 1972; Kurihara et al., 1994a). The positioning of NORs on the 
short arms of acrocentric chromosomes was proposed to isolate rDNA units from 
genes transcribed by Pol II and Pol III. 
Mammalian rDNA transcription units are large, comprising ∼43 kb in humans and 
∼45 kb in mice (Gonzalez and Sylvester, 1995; Grozdanov et al., 2003). 
Sequences encoding pre-rRNA (13–14 kb) are separated by long intergenic 
spacers (IGSs) of approximately 30 kb. Regulatory elements, including gene 
promoters, spacer promoters, repetitive enhancer elements, and transcription 
terminators, are located in the IGS (Figure 2). The rDNA promoter has a bipartite 
structure, consisting of a core promoter element adjacent to the transcription start 
site and an upstream control element (UCE) approximately 100 nucleotides 
further upstream (Haltiner et al., 1986; Learned et al., 1986). Mammalian rDNA 
transcription units are flanked at their 5’ and 3’ ends by one or more terminator 
elements that are recognized by TTF-I (transcription termination factor), a specific 
DNA binding protein that stops elongating Pol I and serves an important role in 
epigenetic regulation of rRNA genes (Grummt et al., 1986a; Grummt et al., 1985; 
Henderson and Sollner-Webb, 1986). The major part of the IGS appears to be 
devoid of regulatory elements, comprising a high density of simple sequence 
repeats and transposable elements (reviewed in (Sylvester et al., 2004)). 
1 Introduction 
 
 
 
34 
 
Figure 2. Structural organization of mouse rRNA gene. Graphic of mouse rRNA genes is 
derived from Genbank accession number BK000964. The sites of transcription initiation of the 45S 
pre-rRNA and transcripts from the intergenic spacer promoter are indicated by arrows. Scale bars 
(in kb) are shown below; 0 kb indicates the 5′ end of the pre-rRNA. Terminator elements located 
downstream of the transcription unit (T1–T10), downstream of the spacer promoter (TSP), and 
upstream of the gene promoter (T0) are marked by red bars. Repetitive enhancer elements 
(purple) located between the spacer promoter and major gene promoter of the mouse gene 
promoter are also indicated. Adapted from (McStay and Grummt, 2008). 
 
Transcription of rDNA by Pol I requires the formation of a preinitiation complex on 
the promoter, including binding of UBF (upstream binding factor) and the promoter 
selectivity factor, termed SL1 in humans and TIFIB in the mouse (Clos et al., 
1986; Grummt, 2003; Moss et al., 2007). UBF affects Pol I transcription at multiple 
levels, functioning as a transcription activator (Bell et al., 1988; Panov et al., 
2006), as an antirepressor (Kuhn and Grummt, 1992; Pelletier et al., 2000) and as 
a regulator of transcription elongation (Stefanovsky et al., 2006). Promoter 
specificity is conferred by SL1/TIF-IB, a ∼300-kDa protein complex that contains 
TBP (TATA box binding protein) and at least three Pol I-specific TBP-associated 
factors (TAFIs), TAFI110/95, TAFI68, and TAFI48 (Comai et al., 1992; Heix et al., 
1997; Zomerdijk et al., 1994). TAFIs perform important roles in transcription 
complex assembly, mediating specific interactions between the rDNA promoter 
1 Introduction 
 
 
 
35 
and Pol I. They interact with UBF and recruit Pol I to rDNA by binding to TIFIA, a 
basal regulatory factor that is associated with the initiation-competent 
subpopulation of Pol I (Pol Iβ). Another important Pol I factor is TTF-I 
(transcription termination factor I), a multifunctional protein that binds to specific 
terminator elements (T1 - T10) downstream of the transcription unit and mediates 
transcription termination and replication fork arrest (Grummt et al., 1986b). A 
similar sequence element, defined as T0 is located immediately upstream of the 
ribosomal gene promoter. The conservation of a binding site for a Pol I 
transcription terminator protein adjacent to the gene promoter suggested that 
TTF-I may also exert some essential function in transcription regulation. Indeed, 
binding of TTF-I to the promoter-proximal terminator was to stimulate in vitro 
transcription of chromatinized rDNA templates by affecting rDNA nucleosomal 
positioning and occupancy at the rDNA promoter (Henderson and Sollner-Webb, 
1986; Langst et al., 1997b). On the other hand, TTF-1 was also shown to bind to 
and to recruit the repressor protein TIP5 that is a key factor for the establishment 
of rDNA silencing (see 1.3.4). 
1.3.2 Intergenic ribosomal RNA (IGS-rRNA) transcription  
In rats, mice, Drosophila and Xenopus, the IGS region contains one or more Pol I 
promoters (spacer promoters) that share sequence homology to the core region of 
the main rDNA promoter (De Winter and Moss, 1986; Grimaldi and Di Nocera, 
1988b; Kuhn and Grummt, 1987; Labhart and Reeder, 1984). Recently, intergenic 
spacer rRNA transcripts (IGS rRNA) were shown to have a crucial function in 
rDNA silencing. In mice, intergenic transcripts originating from the spacer 
promoter that locates approximately 2 kb upstream from the pre-rRNA start site 
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are processed into a heterogeneous population of 200–250 nucleotide RNAs, 
dubbed promoter RNA (pRNA) as their sequence matches the rDNA promoter 
(Mayer et al., 2006). The pRNA associates with nucleolar remodeling complex 
(NoRC, described in 1.3.4), thereby maintaining silencing of rDNA chromatin 
(Santoro et al., 2010b). IGS transcripts are rare, being 1,000-fold less abundant 
than pre-rRNA. The spacer promoter and the main gene promoter have some 
sequence homology, binding of TIF-IB/SL1 and the Pol I-associated factor TIF-IA 
is slightly decreased at the spacer promoter while Pol I is three-fold more 
abundant at spacer promoter than main gene promoter (Santoro et al., 2010a). 
The differences in IGS and pre-rRNA levels can be probably ascribed either to 
stalled Pol I at the spacer promoter or to rapid degradation, as suggested by data 
showing that binding to NoRC stabilizes pRNA (Mayer et al., 2006). Recent 
results indicated two additional factors that can lead to low IGS rRNA abundance 
(Santoro et al., 2010a).  IGS rRNA synthesis was shown to occur during a 
restricted time window of S phase (early) and to originate from a specific set of 
active and hypomethylated rRNA genes that contain 9 enhancer repeats located 
between the spacer and the main gene promoter. These spacer transcripts are 
then processed during mid to late S phase to yield pRNA that is indispensable for 
establishment of silent rDNA chromatin mediated by NoRC (Santoro et al., 
2010a). 
The finding that transcripts from the spacer promoter have an indispensable 
function in epigenetic silencing of rDNA is in apparent disagreement with previous 
studies showing that spacer promoter enhances transcription from the main rDNA 
promoter (Caudy and Pikaard, 2002; De Winter and Moss, 1986; Grimaldi and Di 
Nocera, 1988a; Paalman et al., 1995; Putnam and Pikaard, 1992; Tower et al., 
1 Introduction 
 
 
 
37 
1989). In the “read-through enhancement” model, it was proposed that Pol I 
molecules, which are directed by the spacer promoter to transcribe through the 
enhancer, release rDNA transcription factors from the enhancer and make them 
available to the gene promoter, thereby stimulating gene promoter transcription 
(De Winter and Moss, 1987). A corollary of read-through enhancement models is 
that the spacer promoter must act to somehow amplify or increase the effect 
exerted by the enhancer repeats alone and that the level of stimulation is 
proportional to the transcriptional strength of the spacer promoter. However, 
replacement of mouse spacer promoter by the much more active Chinese 
hamster spacer promoter did not change the level of gene promoter stimulation 
(Paalman et al., 1995). According to these results, enhancement of pre-rRNA 
synthesis does not depend from transcripts originating from spacer promoter and 
imply that spacer promoter affects the main gene promoter using alternative 
mechanisms. One possibility is formation of a loop between the spacer promoter 
and the main gene promoter similar to that one described to occur between rDNA 
main promoter and terminator regions (Nemeth et al., 2008). The spatial 
juxtaposition of both promoters might enhance transcription from the main gene 
promoter by delivering Pol I factors and it would not require IGS rRNA synthesis. 
Consistent with this, recent results identified binding of CTCF and enrichment of 
the histone variant H2A.Z at the spacer promoter (van de Nobelen et al., 2010). 
CTCF is a conserved and ubiquitously expressed protein, which binds DNA and 
organizes chromatin into loops (Phillips and Corces, 2009) while H2A.Z is a mark 
associated with “poised” promoters (Fan et al., 2002). Loop formation within the 
IGS rDNA can be also mediated via dimerization of TTF1 bound to terminator 
elements T0 and T-1, located upstream of the transcription start site of the main 
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gene promoter and downstream of the spacer promoter, respectively (R.S., 
unpublished data). Involvement of TTF-1 in a structure mediating interaction 
between the main gene promoter and the 3’-rDNA region has also been recently 
proposed (Nemeth et al., 2008). The involvement of TTF-1 in forming the spacer-
main gene promoter loop not only suggests that IGS rRNA synthesis is not 
required but that it might not occur at all. The major obstacle that Pol I would 
encounter in transcribing IGS rDNA is TTF1 that, if bound to T0 and T-1 elements, 
might prematurely terminate IGS rRNA transcripts. Thus, when IGS rRNA is 
synthesized, TTF1 should not be bound to either T0 and/or T-1 elements. As 
binding of TTF1 to T0 is a prerequisite for 45S pre-rRNA synthesis (Langst et al., 
1998), it is unlikely that transcription from spacer promoter enhances the strength 
of the main gene promoter in the absence of TTF1. Whether and how binding of 
TTF1 to T0 and T-1 is abrogated during synthesis of IGS rRNA in early S phase, it 
remains an issue to be investigated.  Taken together, all these observations 
suggest that the dual role of spacer promoter in regulating rRNA transcription can 
be distinguished by its capacity either to form a loop or to drive IGS rRNA 
synthesis: in the first case, it stimulates pre-rRNA synthesis; in the second case, it 
is required for NoRC-mediated rDNA silencing (see also 1.3.4).   
1.3.3 Structure and Epigenetic features of rDNA 
One of the earliest and yet still highly informative methods of studying eukaryotic 
gene expression, is by direct electron microscopic visualization of the transcribing 
chromatin (Miller and Beatty, 1969). In S. cerevisiae, due to their ease of 
identification, rRNA genes are the most amenable to study in Miller spreads. 
When spread native rDNA chromatin is visualized, two kinds of rRNA gene units 
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can be observed: 1- transcribing rRNA genes (active copies) that have a 
characteristic tree-like appearance (referred as “Christmas tree”), with a DNA 
"trunk" from which close-packed ribonucleoprotein "branches" of increasing length 
extend; 2- genes that do not associate with Pol I and are not transcribed (silent 
copies). Although the genome complexity of higher eukaryotes does not yet allow 
visualization of rDNA chromatin by Miller spreads, later biochemical studies 
assessed that the coexistence of active and silent rRNA genes in each cell is not 
limited to S.cerevisiae. Differences in chromatin composition between mammalian 
active and silent rRNA genes was initially explored by in vivo crosslinking analysis 
of Friend cells using psoralen, an intercalating drug that can introduce crosslinks 
into DNA sites that are not protected by nucleosomes (Conconi et al., 1989; Sogo 
et al., 1984). Using this method, it was demonstrated that two distinct types of 
ribosomal chromatin coexist in each cell. The fraction of rRNA genes inaccessible 
to psoralen (f-band) contains nucleosomes while the rDNA units accessible to 
psoralen (s-band) display a chromatin structure free of regularly spaced 
nucleosomes. The demonstration that nascent rRNA is selectively associated with 
the heavily psoralen-cross-linked s-band led to the conclusion that the 
nucleosome-free fraction of rDNA is actively transcribed in vivo (active genes) and 
nucleosomal rDNA fraction corresponds to silent genes (Conconi et al., 1989). 
Further studies demonstrated that active and silent rRNA genes are also 
characterized by different epigenetic marks. CpG methylation, an epigenetic mark 
associated with heritable gene silencing and heterochromatic structures, was 
found enriched in the rDNA chromatin fraction inaccessible to psoralen (silent 
genes) and absent from rDNA units accessible to psoralen (active genes) 
(Stancheva et al., 1997). Later studies demonstrated a direct role of DNA 
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methylation in repressing rRNA transcription. Treatment of mouse and human 
cells with 5-azacytidine, an inhibitor of cytosine methylation, increased 45S pre-
rRNA levels, suggesting that lack of DNA methylation alleviates transcriptional 
repression of the corresponding fraction of silent rRNA genes (Santoro and 
Grummt, 2001). Notably, methylation-dependent transcriptional silencing could be 
reproduced in vitro but only when methylated rDNA templates were assembled 
into chromatin. Conversely, transcription on naked rDNA templates was not 
affected, a finding that implies that CpG methylation operates structural changes 
on rDNA chromatin that are incompatible for transcription. The repressive action 
of DNA methylation on rRNA transcription was ascribed to few critical CpGs within 
the rDNA promoter region. In mouse, methylation of a single CpG within the UCE 
(upstream control element) of rDNA promoter located at -133 impairs binding of 
the Pol I transcription factor UBF (upstream binding factor) to rDNA chromatin, 
thereby preventing initiation complex formation. Consistent with this, methylation 
of one single HpaII site (CCGG), located in the rat promoter region of silent rDNA 
chromatin inaccessible to psoralen crosslinking, showed particularly strong 
correlation with the repressed transcriptional state (Stancheva et al., 1997). The 
correlation between rDNA methylation and transcriptional silencing is further 
supported by studies in tumours where rRNA transcription is usually upregulated. 
Hypomethylation of the rRNA genes has been observed in lung cancer, Wilms 
tumor and hepatocellular carcinoma (Ghoshal et al., 2004; Powell et al., 2002; Qu 
et al., 1999; Shiraishi et al., 1999). 
The finding that the fraction of silent rRNA genes is enriched in CpG methylated 
sequences made possible to analyze the composition of silent and active rDNA 
chromatin in higher eukaryotes and plants. An assay based on chromatin 
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immunoprecipitation (ChIP) coupled to CpG methylation measurement (ChIP-
chop) was developed (Santoro et al., 2002), allowing to identify protein factors, 
including posttranslational modified histones, that bind either to active (i.e. lack of 
meCpG) or to silent (i.e. enriched in meCpGs) genes. Using this approach, 
several studies showed that the promoter of mouse and human active rRNA 
genes associated with Pol I transcription factors and with histones modified with 
active marks (i.e. H4Ac and H3K4me2) (Santoro and Grummt, 2005; Santoro et 
al., 2002). In contrast, silent rRNA genes are associated with the heterochromatin 
protein 1 (HP1) and with histones modified with silent marks like H3K9me2, 
H3K27me3, H4K20me3 (Santoro and Grummt, 2001, 2005; Santoro et al., 2002). 
A similar epigenetic pattern was also described in plants (Lawrence et al., 2004). 
Thus, active and silent rRNA genes are demarcated both by their pattern of DNA 
methylation and by specific posttranslational modified histones (Figure 3). 
 
 
Figure 3. Model: Active and silent rRNA genes 
 
Another important feature that distinguishes active from silent rRNA genes is the 
replication timing. In mouse and human cells, rRNA genes are replicated in a 
biphasic manner: the active rRNA genes replicate early, whereas silent rDNA 
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arrays replicate late (Berger et al., 1997; Li et al., 2005). rDNA replication timing is 
controlled allelically, with one allele replicating early and one replicating late in 
almost every cell (Schlesinger et al., 2009). Although the mechanisms of 
inheritance of active rDNA chromatin remain still elusive, the identification of the 
nucleolar remodeling complex NoRC led to important advances in the elucidation 
of the mechanisms controlling maintenance of silent rDNA chromatin in mammals 
(Santoro et al., 2002; Strohner et al., 2001) (see 1.3.4). 
1.3.4 NoRC complex 
A yeast two-hybrid screen searching for TTFI- interacting proteins that have the 
potential to alter the chromatin structure of the rDNA promoter has identified a 
chromatin remodeling complex, termed NoRC (nucleolar remodeling complex), 
which induces nucleosome sliding in an ATP-dependent and a histone H4 tail–
dependent fashion (Strohner et al. 2001). NoRC consists of TIP5 (TTF1-
interacting protein 5) and the ATPase SNF2h and is the key determinant in setting 
heterochromatic and silent features at the rDNA locus during cell division (Li et al., 
2005; Santoro et al., 2002; Zhou et al., 2002). TIP5, the largest subunit of NoRC, 
shares a number of important domains with other subunits of known human 
remodeling complexes like ACF, WCRF, CHRAC and WICH (Bochar et al., 2000; 
Bozhenok et al., 2002; Ito et al., 1999; LeRoy et al., 1998; Poot et al., 2000). Such 
shared domains include a bromodomain, a PHD (plant homeodomain) finger, 
WAKZ motifs, a BAZ1 and a BAZ2 motif as well as AT-hooks (Figure 4). Initial 
studies showed that NoRC-mediated rDNA transcriptional repression did not 
occur in the presence of DNA methylation and histone deacetylase inhibitors, 
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implicating that NoRC acts by inducing DNA methylation and histone 
deacetylation at rDNA.   
 
 
Figure 4.  Modular organization and domains of TIP5 (TTF-I-interacting protein 5). Scheme 
illustrating the modular organization and localization of sequence motifs in TIP5 that have been 
associated with functions in chromatin structure and function. The domains of TIP5 (colored 
boxes) that interact with proteins involved in the epigenetic control of gene expression are 
illustrated. The C-terminal part of TIP5 contains a PHD (plant homeodomain) finger that interacts 
with SNF2h and with histone methyltransferases (HMTs) and a bromodomain that interacts with 
histone deacetylases (HDAC1 and -2) and with histone H4 acetylated at lysine 16 (H4K16ac). 
DNA methyltransferases (DNMTs) interact with both the internal and the C-terminal part of TIP5. 
The MBD (methyl-CpG binding domain)-like TAM (TIP5/ARBD/MBD) domain is required for 
association with pRNA that in turn mediates the association with the poly(ADP-ribose) polymerase 
I (PARP1) that is required for NoRC-mediated rDNA heterochromatin formation.  
 
TIP5 was shown to associate with methylated rDNA sequences (Santoro et al., 
2002). The association of TIP5 with TTF1 and its dependency on rDNA binding let 
propose a mechanism of TIP5 targeting to rDNA through DNA-protein recognition, 
where TTF1 represents the docking protein due to it sequence-specific binding to 
T0 element (Nemeth et al., 2004; Santoro and Grummt, 2005; Strohner et al., 
2001). TIP5 acts as platform for the recruitment of histone-modifying and DNA 
methylating activities (i.e. HDAC1, SETDB1, SIRT1, MOF, Dnmts) (Santoro and 
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Grummt, 2005; Santoro et al., 2002; Zhou et al., 2002; Zhou et al., 2009) and 
represses rRNA transcription. In somatic cells, the association of NoRC with rRNA 
genes was shown to take place immediately after rDNA replication in late S phase 
(Li et al., 2005), suggesting a role of NoRC in maintaining the epigenetic and 
chromatin state of newly duplicated silent rRNA genes. NoRC was shown to 
position a nucleosome over the rDNA promoter of silent genes (from -132 to +22) 
(Li et al., 2006). Noteworthy, in this ‘inactive’ position, the critical CpG dinucleotide 
at -133, whose methylation prevents binding of UBF, is placed at the 5’ boundary 
of the nucleosome (Santoro and Grummt, 2001). In this position, not hindered by 
a nucleosome, the CpG-133 would be exposed to methylation mediated by Dnmts 
associated with NoRC (Santoro et al., 2002). In support of this, impairment of 
nucleosome remodelling activity of NoRC abrogates transcriptional repression 
and CpG methylation of an rDNA reporter gene (Santoro and Grummt, 2005).  
NoRC function requires the association of TIP5 with the non-coding RNA pRNA 
(Mayer et al., 2006; Santoro et al., 2010a). Nucleolar retention of TIP5, rDNA 
methylation and silent histone modifications at rDNA depend on pRNA (Mayer et 
al., 2006). Importantly, a TIP5 mutant with impaired RNA binding activity (W531G, 
Y532A) failed to establish rDNA heterochromatin (Mayer et al., 2006). pRNA 
sequences from nucleotides -127 to -49 in mouse form a conserved hairpin 
structure that is specifically recognized by the TIP5-TAM domain. Upon pRNA 
binding, TIP5 undergoes a conformational change that was proposed to facilitate 
the interaction with other proteins required for rDNA silencing (Mayer et al., 2008). 
Recently, the poly (ADP-ribose) polymerase I (PARP1) was identified as a TIP5 
interacting protein (Guetg et al., 2012). Association of PARP1 with TIP5 is 
mediated by pRNA and is necessary for the establishment of rDNA 
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heterochromatic structures. Recruitment of PARP1 occurring at newly synthesized 
silent rDNA copies and the role of pRNA in this process support the idea that 
specific non-coding RNA can potentially direct complex patterns of chromatin 
states at specific genes in a spatially and temporally organized manner.  
1.3.5 Nucleolar chromatin 
Despite the nucleolus is the most active site of cellular transcription, a shell of 
highly condensed heterochromatic DNA replicating in mid-late S-phase surrounds 
the nucleolus of interphase cells (Haaf and Schmid, 1991; Pluta et al., 1995). In 
mouse, these sequences mainly represent repetitive major satellite (pericentric) 
and minor satellite (centric) repeats whose maintenance and accurate duplication 
throughout multiple cell divisions represents a major challenge to ensure genome 
stability (Guetg et al., 2010). The proximity of these heterochromatic sequences 
around the nucleolus is partially due to the linear close location next to rRNA 
repeats. As mentioned, human rRNA genes are located between the short arm 
and the satellite body of acrocentric chromosomes while mouse rRNA repeats 
cluster within the centromeric regions of chromosomes 12, 15, 16, 18 and 19 (Dev 
et al., 1977; Kurihara et al., 1994b). Although the nucleolar proximity of some 
centromeric heterochromatic repeats can be explained by their linear location 
close to rRNA repeats (Dev et al., 1977; Kurihara et al., 1994b), other 
centromeres of chromosomes not containing rRNA genes associate with the 
nucleolus at a frequency more than that expected for a random distribution 
(Carvalho et al., 2001), suggesting that the nucleolus might be an attractive 
compartment of nuclear heterochromatic regions. Similarly, the inactive X-
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chromosome was reported to contact the nucleolus during mid-to-late S-phase 
and this location seems to be required for the duplication of silent chromatin 
structures(Zhang et al., 2007). The presence of non-nucleolar domains within or 
close to the nucleolus is also supported by genomic analysis demonstrating that 
4% of the entire genome sequences interact with nucleoli of HeLa cells (van 
Koningsbruggen et al., 2010). These sequences correspond to rDNA, 
pericentromeric and centromeric repetitive sequences, and to regions with low 
gene density and significantly enriched in transcriptionally repressed genes 
(Nemeth et al., 2010; van Koningsbruggen et al., 2010). To note is that lamina 
associated domains (LADs) that are relatively gene-poor and have a repressive 
chromatin signature, were also found relocated next to the nucleolus (Kind et al., 
2013; Kind and van Steensel, 2010). Therefore, anchoring of heterochromatin at 
the nucleolus might serve similar functions like the ones described for the nuclear 
periphery that is responsible for the integrity of mammalian heterochromatin 
(Pinheiro et al., 2012; Towbin et al., 2012), suggesting interchangeable roles in 
regulating and maintaining heterochromatic states.   
Taken together, these results paint a two-sided picture that represents the 
nucleolus as the most active site of cellular transcription and, at the same time, 
the place where heterochromatic repressive structures are retained and most 
probably maintained.  
The coexistence of active and silent rRNA genes might reflect these two opposite 
functions of the nucleolus. Maintenance of silent rDNA chromatin appears to be 
necessary for the stability of rRNA genes. In the yeast S. cerevisiae, recruitment 
of the nucleolar protein complexes RENT (regulator of nucleolar silencing and 
telophase exit) and Cohibin to rDNA suppresses unequal recombination at the 
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rDNA repeats (Mekhail et al., 2008). This suppression is seemingly linked to the 
ability of these complexes to induce rDNA silencing. Similarly, segments of rRNA 
genes and satellite repeat arrays become dispersed in Drosophila mutants that 
are defective in the histone methyltransferase Su(var)3-9, in HP1 (HP1 1, also 
known as Su(var)2-5) or in several genes involved in the RNA interference (RNAi) 
pathway (Peng and Karpen, 2007).  
  
Figure 5. Crosstalk between nucleolar rDNA heterochromatin and nuclear heterochromatin. 
Right panel. A shell of heterochromatin surrounds the nucleolus. Immunofluorescence of MEF 
cells showing heterochromatic foci, characterized by H3K9me3 and DAPI staining, located close to 
nucleoli (visualized by the nucleolar Pol I transcription factor UBF). Left panel. rDNA 
heterochromatin and its associated components (here shown TIP5, SNF2h, PARP1 and pRNA) 
influence centric and pericentric heterochromatin located at the nucleolar periphery (Guetg et al., 
2010; Guetg et al., 2012). Modified from (Guetg and Santoro, 2012) . 
 
The role of heterochromatic silent rRNA genes seems to go beyond the regulation 
of rRNA synthesis and rRNA stability by playing important roles at the level of 
nuclear/nucleolar chromatin architecture. A yeast strain containing a reduced 
number of rRNA genes that transcribe at high rate to compensate the absence of 
about 100 copies (143 rRNA repeats in the wild-type strain), yet displays a 
fraction of 10-20% of silent rDNAs (French et al., 2003; Merz et al., 2008). The 
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presence of silent rDNA copies in a strain where bona fide all rRNA genes should 
be dedicated to transcription suggests that silent repeats play an indispensable 
role not necessarily related to transcription. In mouse and human cells, silent 
rDNA arrays are located in the extranucleolar space, frequently associated with 
the perinucleolar centromeric heterochromatin (Akhmanova et al., 2000; 
Mosgöller, 2004), suggesting an intricate relationship between these two types of 
heterochromatic regions. The establishment of silent rDNA heterochromatin has 
been recently linked to the formation of centric-pericentric heterochromatin 
(Figure 5). Impairment of the rDNA silencing machinery through depletion of TIP5 
denies formation of perinucleolar heterochromatin and decreases heterochromatic 
marks (i.e. H3K9me3) at major and minor satellite repeats (Guetg et al., 2010). 
Similarly, overexpression of TIP5 increased H3K9me3 levels at rRNA and 
centric/pericentric repeats. Also in this case, maintenance of silent rDNA 
chromatin seems to play an important role for genome stability. TIP5-mediated 
heterochromatin formation was reported to specifically protect CpG methylated 
silent rRNA genes from illicit recombination events whereas active genes are not 
affected. Similarly, genomic instability was also observed at pericentric 
heterochromatin of cells depleted of TIP5 (Guetg et al., 2010). Centromeric 
protein CENP-A and major/minor satellites were shown to associate with TIP5 
and it was proposed that the spatial and linear closeness of rDNA and satellite 
sequences may allow TIP5 to interact with centric repeats and aids in establishing 
heterochromatic structures using similar mechanisms as used to silence the rDNA 
locus. Alternatively, the influence of TIP5 and silent rRNA genes may affect the 
centric and pericentric heterochromatin either by spreading mechanisms or by 
creating a nucleolar/perinucleolar compartment enriched in chromatin repressor 
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complexes. In both cases, decrease of rDNA silencing after TIP5 depletion would 
affect the spreading of heterochromatin and reduce the levels of repressor 
complexes within and nearby the nucleolus. A functional link between rDNA 
repeats and nuclear heterochromatin could also be observed in Drosophila. In this 
case, rDNA deletions result in reduced heterochromatin-induced gene silencing 
elsewhere in the genome and the extent of the rDNA deletion correlates with the 
loss of silencing (Paredes and Maggert, 2009). 
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2 Aims 
Despite sharing the same genome, different cell types from a given organism 
respond differently to environmental, developmental, or metabolic cues. This 
variable property is a defining aspect of a cell’s identity and is mainly interpreted 
at the level of epigenetic signature and chromatin structure.  
Embryonic stem cells (ESCs) are able to self-renew indefinitely and to 
differentiate into all cell types of the three germ layers. This dual capacity makes 
ESCs a potential source for cell and tissue replacement. In order to make these 
potential clinical applications a reality, intensive research on the mechanisms of 
pluripotency and ESC differentiation must be carried out.  
Chromatin organization and epigenetic signature distinguish pluripotent ESCs 
from somatic cells. A less compacted chromatin structure and higher levels of 
euchromatic histone modifications allow ES chromatin to assume a globally more 
open conformation than in somatic cells. These chromatin properties seem to 
reflect the plasticity of the genome in ESCs and likely contribute to the 
maintenance of pluripotency. However, how these changes occur during the ESC 
differentiation process is not yet clear.  
 
The aim was this work was: 
1- to analyze the chromatin and epigenetic signature of rRNA genes in ESCs 
and during differentiation; 
2- to elucidate the mechanisms that control formation of rDNA 
heterochromatin during stem cell differentiation; 
3- to determine whether the epigenetic state of the nucleolus regulates 
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chromatin plasticity in ESCs and remodelling into heterochromatin upon 
differentiation. 
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Abstract  
 
Clustering of heterochromatin at nucleoli is a phenomena occurring in many 
organisms, yet its physiological relevance is poorly understood. Using ncRNA-
based strategies to target heterochromatin at nucleoli of embryonic stem cells 
(ESCs), we investigated whether the nucleolus regulates chromatin plasticity in 
ESCs and remodelling into heterochromatin upon differentiation. In ESCs, rRNA 
genes are euchromatic due to the impairment of ncRNA pRNA processing that 
abrogates recruitment of nucleolar repressor TIP5. Upon differentiation, 
processing is activated and mature pRNA establishes nucleolar heterochromatin, 
concurrently with nuclear heterochromatin formation. Tethering heterochromatin 
at ESC nucleoli through pRNA initiates heterochromatinization of ESC genome, 
including global H3K9me2 increase and silencing at repetitive sequences like it is 
found in differentiated cells. Nucleolus-mediated heterochromatic ESCs transcribe 
differentiation genes and are not longer pluripotent, while inhibition of nucleolar 
heterochromatin prevents differentiation. Our finding unravelled the nucleolus as a 
regulator of chromatin plasticity and pluripotency and challenges current view on 
heterochromatin regulation and function in ESCs. 
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Introduction 
 
The spatiotemporal organization of the genome in the nucleus is an emerging key 
player to regulate genome function. The cell nucleus is a highly structured 
compartment where chromatin is distributed in subdomains based on compaction 
degree and transcriptional status (Gonzalez-Sandoval et al., 2013; Joffe et al., 
2010). Remarkably, transcriptionally silent heterochromatin clusters together at 
the nuclear periphery and around the nucleolus, suggesting that this spatial 
distribution may be regulated, and could influence cell activities. ESC chromatin is 
a global decondensed structure lacking “conventional” constitutive 
heterochromatin (Efroni et al., 2008; Jorgensen et al., 2007; Melcer et al., 2012; 
Meshorer et al., 2006). Such a structure correlates with a globally permissive 
transcriptional state and it has been proposed to contribute to the developmental 
plasticity and pluripotency of ESC genome that has to have the ability to enter any 
distinct differentiation pathway (Meshorer and Misteli, 2006). As differentiation 
advances, large-scale genome silencing takes place and ESC chromatin 
undergoes structural remodelling toward a highly condensed heterochromatic 
form (Bhattacharya et al., 2009; Meshorer et al., 2006; Park et al., 2004). 
Changes in nuclear architecture are characterized by the maturation of centric 
and pericentric heterochromatin (Aoto et al., 2006; Bartova et al., 2008b; Efroni et 
al., 2008), formation of large genomic regions enriched in H3K9me2 (LOCKs) 
(Wen et al., 2009), anchoring of multigene regions at the nuclear periphery (Peric-
Hupkes et al., 2010) and clustering of centromeres either at the nucleolus or at 
the nuclear envelop (Bartova et al., 2008a; Wiblin et al., 2005). However, how 
ESCs mediate the switch from a lower to a higher order chromatin structure and, 
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in turn, its spatial distribution within the cell still remains elusive and calls for 
studies aimed to understand the mechanistic and functional insights of this 
process. 
The nucleolus is the compartment where transcription of hundreds of ribosomal 
RNA (rRNA) genes, rRNA processing, and ribosome subunit assembly take place 
(Haaf and Schmid, 1991; Pluta et al., 1995). Clustering of heterochromatin at 
nucleoli is a phenomenon known to occur in many different organisms and cell 
types, yet neither the factors involved nor their physiological relevance is 
understood. Within the nucleolus of somatic cells, a fraction of rRNA genes (about 
400 in mouse and human cells) is transcriptionally silent, possesses epigenetic 
features characteristic of constitutive heterochromatin and is stably inherited 
independently of cell metabolic activities (Conconi et al., 1989; Santoro and 
Grummt, 2001; Santoro et al., 2002). In mouse and human cells, silent rDNA 
arrays are located in the extranucleolar space, frequently associated with 
centromeric heterochromatin (Akhmanova et al., 2000; Mosgöller, 2004), 
suggesting an intricate relationship between these two types of heterochromatic 
regions. TIP5 (TTF1-interacting protein 5), the main subunit of the nucleolar 
remodeling complex NoRC, establishes rDNA heterochromatin through 
recruitment of DNA and histone modifier complexes (Guetg et al., 2012; Santoro 
and Grummt, 2005; Santoro et al., 2002). The activity of TIP5 to form 
heterochromatin at rDNA requires the association with the long non-coding 
(lnc)RNA pRNA  (Guetg et al., 2012; Mayer et al., 2006; Santoro et al., 2010a). 
pRNA has been implicated in TIP5 nucleolar retention and the association with 
rDNA. However, it remains still elusive whether and how pRNA acts as guider for 
TIP5 recruitment to rDNA.  
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In this study, we investigated whether the nucleolus is implicated in the open and 
transcriptional permissive chromatin organization and pluripotency of ESCs and 
its contribution in the remodelling into heterochromatic structures that occurs upon 
ESC differentiation. We found that rRNA genes lack heterochromatin in ESCs and 
acquire epigenetic silent marks upon ESC differentiation, timely coinciding with 
the maturation of “conventional” constitutive heterochromatic sequences such as 
centric and pericentric repeats. We determined the mechanistic and functional 
insights of this process by unravelling an unsuspected role of ncRNA processing 
in epigenetic and chromatin regulation. We showed that the determinant for the 
lack of rDNA heterochromatin in ESCs is the impairment of processing of pRNA 
precursor intergenic spacer (IGS)-rRNA. Upon ESC differentiation processing is 
activated and produces mature pRNA that has the ability to establish 
heterochromatin by guiding TIP5 to rDNA through the association of TIP5 with 
TTF1, which docks the complex at rDNA. In contrast, the unprocessed IGS-rRNA 
transcript impairs TIP5-TTF1 association and recruitment to rDNA, abolishing 
formation of rDNA heterochromatin in ESCs. Consistently, addition of mature 
pRNA in ESCs is sufficient to establish rDNA heterochromatin. Tethering of 
heterochromatin at nucleoli of ESCs through ectopic mature pRNA initiates 
structure remodelling of nuclear architecture toward a highly condensed 
heterochromatic form like it is found in differentiated cells, including a global 
increase in H3K9me2, transcriptional repression at repetitive sequences, and 
activation of differentiation genes. Nucleolus-mediated heterochromatic ESC 
genome is not longer pluripotent, while inhibition of nucleolar heterochromatin 
through depletion of TIP5 prevents exit from the undifferentiated state. Together 
the results indicate that the nucleolar chromatin is an important regulator of 
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nuclear architecture by controlling chromatin plasticity and pluripotency of ESCs. 
Moreover, the data unravel a further level of complexity of ncRNA regulation and 
propose RNA processing as a way to modulate distinct and specific features of 
the same ncRNA.  
 
Results 
 
Establishment of rDNA heterochromatin occurs during ESC differentiation 
To determine whether the epigenetic state of the nucleolusis is regulated upon 
ESC differentiation, we analyzed the rDNA chromatin state during transition of 
ESCs into neural progenitor cells (NPCs) that are Pax-6 positive and do not 
express the pluripotency factor Nanog (Figure 1A) (Bibel et al., 2004). Previous 
studies showed that methylation of the two unique CpG dinucleotides at the 
mouse rDNA promoter is the epigenetic mark that distinguishes active and silent 
rRNA genes (Santoro and Grummt, 2001). To determine the content of active and 
silent repeats, we measured CpG methylation at rDNA promoter of ESCs, NPCs 
and mouse somatic cells from brain tissue using HpaII digestion followed by 
qPCR, a method that accurately quantifies the amounts of silent, heterochromatic 
rRNA genes (Santoro et al., 2002). Consistent with a previous bisulfite analysis 
(Schlesinger et al., 2009), rDNA promoter in ESCs displays very low meCpG 
levels, confirming the accuracy of our method. After 8 days of differentiation, a 
fraction of rRNA genes (25-30%) acquired CpG methylation at levels similar to 
those measured in mouse brain tissue (Figure 1B). Similar results were also 
obtained with a different ESC line and differentiation protocol (Figure S1A), 
suggesting that de novo rDNA methylation is a process that takes place during 
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early ESC differentiation. Consistent with these results, 45S pre-rRNA amounts 
were lower in NPCs than in ESCs and similar to mouse fibroblast NIH3T3 cells 
(Figure1C). Remarkably, rDNA methylation in induced pluripotent stem cells 
(iPSC) decreased to about one half when compared to the original fibroblast cells 
(Figure 1D), implying a link between cell pluripotency and rDNA methylation 
levels. Analysis of heterochromatin-related histone modifications H3K9me2, 
H3K9me3 and H3K27me3 at rDNA (Figure 1E, Figure S1B) revealed that upon 
differentiation all these histone modifications increased at rDNA promoter and 
coding regions, indicating that rDNA heterochromatin formation takes place during 
ESC-NPC transition. Consistent with previous reports showing heterochromatin 
maturation during ESC differentiation, H3K9me3 levels increased at major and 
minor satellite repeats (Martens et al., 2005; Meshorer et al., 2006; Wong et al., 
2009) while H3K9me2 occupancy was not greatly affected. The increase in 
heterochromatic marks during ESC-NPC was accompanied by a reduction of 
transcription levels of major and minor satellites, which are normally repressed in 
differentiated cells (Figure S1C) (Efroni et al., 2008). We conclude that formation 
of rDNA heterochromatin takes place during ESC-NPC transition and it timely 
coincides with the switch to a higher condensed heterochromatic form of centric 
and pericentric repeats.  
 
TIP5 is recruited to rDNA during ESC differentiation 
To determine how rDNA heterochromatin is established during ESC 
differentiation, we measured the association of Pol I upstream binding factor UBF, 
that exclusively binds to unmethylated active rRNA genes, and of TIP5, which 
associates with methylated silent rDNA (Santoro and Grummt, 2001; Santoro et 
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al., 2002). As shown in Figure 1F, UBF occupancy at rDNA was lower in NPCs 
than in ESCs, a further indication that the number of euchromatic active rRNA 
genes decreases during differentiation. In contrast, TIP5 binds to rDNA only in 
NPCs but not in ESCs (Figure 1F). Similarly, the poly(ADP-ribose)-polymerase-1 
(PARP1), previously shown to interact with TIP5 via pRNA and implicated in the 
formation of rDNA heterochromatin (Guetg et al., 2012), increases its association 
with the rDNA promoter in NPCs. These results indicate that the establishment of 
rDNA heterochromatin in ESC-NPC transcription is accompanied by a decrease in 
the association of factors specific to active genes and an increase in the binding 
of components of the rDNA silencing machinery.  
TIP5 protein and mRNA levels were higher in ESCs than in NPCs (Figure 1G), 
implying that the lack of rDNA heterochromatin in ESC and its establishment 
during ESC differentiation is independent of TIP5 amounts. We then analyzed the 
cellular localization of TIP5 in mouse embryonic fibroblasts (MEFs), ESCs and 
NPCs (Figure 1H). Consistent with previous results, TIP5 was exclusively 
localized within nucleoli of somatic MEFs (Strohner et al., 2001). In contrast, the 
cellular localization of TIP5 in ESCs was predominantly nucleoplasmic and often 
excluded from the nucleoli. After 8 days of differentiation, TIP5 was drastically 
reduced in the nucleoplasm and exclusively localized within the nucleoli of NPCs, 
showing a cellular localization that is characteristic of all somatic cells analyzed so 
far (Figure 1H, lower panel). We conclude that binding of TIP5 to rDNA is 
impaired in ESCs and its recruitment to rDNA is achieved upon ESC 
differentiation.  
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Processing of pRNA mediates formation of rDNA heterochromatin 
We reasoned that impairment of TIP5 binding to rDNA might be responsible for 
the lack of rDNA heterochromatin in ESCs. Previous studies showed that the 
association of pRNA with TIP5 is required to form rDNA heterochromatin by 
mediating nucleolar retention of TIP5, the association with rDNA and the 
interaction with PARP1 (Guetg et al., 2012; Mayer et al., 2006). pRNA is a 250-
300 nt transcript complementary to rDNA promoter sequences and derives from 
the processing of IGS-rRNA whose synthesis is driven by an alternative rDNA 
promoter that  is located 2 kb upstream of the pre-rRNA transcription start site in 
mouse genome (Mayer et al., 2006; Santoro et al., 2010a) (Figure 2A). To 
analyze whether pRNA is implicated in the lack of rDNA heterochromatin in ESCs, 
we initially measured pRNA levels in ESCs and at different time points of 
differentiation by strand specific reverse transcription (RT) (Figure 2B). 
Measurements of pRNA region from -165 to -20 did not reveal remarkable 
differences between ESCs and NPCs, indicating that formation of rDNA 
heterochromatin in NPCs does not depend on the amounts of pRNA sequences. 
Since amplifications of pRNA sequences do not distinguish between IGS-rRNA 
and mature pRNA, we quantified the levels of unprocessed transcripts by 
amplifying the 5’- and internal IGS-rRNA regions (Figure 2B). Unprocessed 
transcript levels were higher in ESCs than in NPCs, suggesting that IGS-rRNA 
processing in ESCs is less efficient than in NPCs. To support these results, we 
constructed an IGS-rRNA reporter gene plasmid that allows measurements of 
ectopic IGS-rRNA and pRNA (Figure 2C, left panel). We transfected the reporter 
gene in NIH3T3 cells, previously described to have an efficient IGS-rRNA 
processing (Santoro et al., 2010a), and in ESCs and measured ectopic pRNA and 
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IGS-rRNA levels (Figure 2C). While ectopic IGS-rRNA was efficiently processed 
in NIH3T3 cells (80%), maturation of pRNA was strongly reduced in ESCs. Taken 
together these results indicate that IGS-rRNA is not efficiently processed in ESCs 
and that it is less abundant in NPCs than in ESCs.  
To test whether the lack of IGS-rRNA processing is the determinant that impairs 
formation of rDNA heterochromatin in ESCs, we transfected in vitro synthesized 
mature pRNA in ESCs and monitored TIP5 cellular localization, rDNA methylation, 
rRNA transcription, and H3K9me2 and H3K9me3 levels at rDNA (Figure 3). In 
ESCs transfected with pRNA, TIP5 decreased in the nucleoplasm and 
accumulated within nucleoli, as indicated by the colocalization with the nucleolar 
protein UBF (Figure 3A). Remarkably, ectopic pRNA in ESCs reduced 45S pre-
rRNA levels and increased both H3K9me2 and CpG methylation levels at the 
rDNA promoter (Figures 3B-D, Figure S2). The modest increase in CpG 
methylation (from 1.7% to 4.4%) can be also attributed to the 2i conditions that we 
used to culture ESCs, recently described to lead to pronounced reduction in DNA 
methylation due to the downregulation of the de novo methyltransferases 
DNMT3a and DNMT3b (Leitch et al., 2013). Consistent with previous studies 
showing that TIP5 mediates dimethylation but not trimethylation of H3K9 at rRNA 
genes (Guetg et al., 2010; Santoro and Grummt, 2005), ectopic pRNA did not 
increase H3K9me3 levels at rDNA (Figure 3D). These results indicate that 
addition of pRNA in ESCs is sufficient to guide TIP5 to rDNA and to establish 
rDNA heterochromatin. 
To determine how pRNA guides TIP5 to rDNA, we mutated pRNA sequences that 
were previously implicated in rDNA methylation and TIP5 association in somatic 
cells (Mayer et al., 2008; Schmitz et al., 2010). First, we transfected ESCs with a 
3 Results 
 
 
 
63 
pRNA mutant (pRNAΔT0) whose sequences corresponding to the T0 element at 
the rDNA promoter were replaced with unrelated nucleotides (Figure 3A). These 
sequences were previously described to form dsDNA:RNA triplex, a structure 
implicated in de novo rDNA methylation through recruitment of DNMT3b (Schmitz 
et al., 2010) and recently proposed as guiding module for TIP5 targeting to rDNA 
(Bierhoff et al., 2013). However, transfection of pRNAΔT0 induced recruitment of 
TIP5 to nucleoli and promoted rDNA methylation as seen in ESCs containing wild-
type pRNA (Figures 3A, B), indicating that nucleolar targeting of TIP5 and de 
novo rDNA methylation in ESCs is not mediated by rDNA:pRNA triplex. 
Consistent with these results, replacement of the 5’-pRNA region (Control-pRNA) 
which includes T0 element induced TIP5 nucleolar localization (Figure 3E). In 
contrast, replacement of 3’-pRNA sequences (pRNA-Control), previously reported 
to form a stem-loop structure that is necessary for the association with TIP5 in 
vitro (Mayer et al., 2008), impairs nucleolar localization of TIP5. Remarkably, point 
mutations that disrupt the stem-loop structure were not efficient in recruiting TIP5 
to the nucleoli while a compensatory mutation allowing hairpin formation did it. 
Together, these results indicate that pRNA guides TIP5 to rDNA in trans through 
the hairpin structure and that addition of mature pRNA in ESCs is sufficient for the 
establishment of rDNA heterochromatin. We conclude that the impairment of IGS-
rRNA processing that abrogates formation of mature pRNA is the major 
determinant causing the lack of rDNA heterochromatin in ESCs. 
 
TIP5-TTF1 association is mediated by pRNA and impaired by IGS-rRNA 
Why is IGS-rRNA unable to promote recruitment of TIP5 to rDNA? We first 
determined whether TIP5 binds to IGS-rRNA. Recombinant TIP5 was incubated 
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with nonspecific radiolabeled transcripts (McStay and Grummt), and TIP5/RNA 
complexes were challenged with increasing amounts of RNA-control, pRNA and 
IGS-rRNA (Figure 4A). Consistent with previous results, pRNA had a higher 
affinity for TIP5 compared to control RNA (Mayer et al., 2006). Surprisingly, IGS-
rRNA not only efficiently competed for TIP5 association but also displayed a 
higher affinity than pRNA. To determine whether TIP5 has a better binding affinity 
to other sequences within IGS-rRNA than to pRNA, we compared TIP5 
association with pRNA, spacer region and enhancer-repeat RNA. As shown in 
Figure S3A, spacer and enhancer sequences were much less efficiently 
associated with TIP5 than pRNA, suggesting that TIP5 binds to IGS-rRNA through 
the pRNA sequences and that upstream sequences might stabilize the complex 
through weak interactions. Together, these results indicate that TIP5 has the 
ability to bind to pRNA sequences within IGS-rRNA and suggest that impairment 
of TIP5 binding to rDNA in ESCs might depend on the context of this interaction.  
The experiments described in Figure 3 showed that TIP5 targeting to rDNA is not 
mediated by pRNA:rDNA triple helix but depends on the 3’-pRNA region that was 
previously shown to interact with TIP5 (Mayer et al., 2008). We hypothesized that 
pRNA binding to TIP5 might favour the association with a docking protein for the 
recruitment to rDNA promoter sequences and that IGS-rRNA might hinder this 
process. One important TIP5 interacting protein is the transcription terminator 
factor TTF1 (Nemeth et al., 2004; Strohner et al., 2001). Indeed, TIP5 was 
identified with a two-hybrid screen with TTF1 as bait. TTF1 binds to terminator (T) 
elements, sequences located at the 5’- and 3’-rDNA regions, and is implicated in 
several rDNA regulatory processes such as transcript termination, replication fork 
arrest and transcription (Evers and Grummt, 1995; Gerber et al., 1997; Langst et 
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al., 1997a). The association of TIP5 with TTF1 and its dependency on rDNA 
binding proposed that TTF1 recruits TIP5 to rDNA (Nemeth et al., 2004; Santoro 
and Grummt, 2005; Strohner et al., 2001). However, whether and how pRNA is 
implicated in this process has so far not been investigated. TTF1 binds to RNA 
(Figure 4B), forming high molecular weight complexes that are probably due to 
the known ability of TTF1 to dimerize (Sander and Grummt, 1997). However, in 
contrast to TIP5, TTF1 did not display any preferential binding to pRNA 
sequences (Figure 4C). As in ESCs TTF1 is bound to rDNA promoter region 
(Figure S3B), we analyzed whether the association of TIP5 with TTF1 is 
regulated by pRNA or IGS-rRNA. To do this, we performed pulldown assays using 
purified RNA-free His-tagged TTF1 (aa.1-210, containing TIP5-interacting region) 
and GST-tagged-TIP5 (aa. 332-723, comprising the RNA- and TTF1-interacting 
regions) (Figure 4D) (Mayer et al., 2006; Nemeth et al., 2004). In this assay, we 
first bound GST or GST-TIP5332-723 to glutathione beads and then we incubated 
GST-bound proteins either with no RNA, or with equivalent moles of RNA-control, 
pRNA or IGS-rRNA. Subsequently, bound GST-TIP5±RNA complexes were 
assayed for the interaction with His-TTF11-210. In the absence of RNA and in the 
presence of RNA control, TIP5 and TTF1 did not associate (Figure 4D). In 
contrast, TIP5-pRNA complexes displayed a strong interaction with TTF1, 
indicating that pRNA is required for TIP5-TTF1 association. Remarkably, TIP5 
bound to IGS-rRNA did not interact with TTF1 (Figure 4D, left panel). Consistent 
with the role of 3’-pRNA sequences in TIP5 nucleolar targeting (Figure 3E), this 
region was sufficient for TIP5-TTF1 interaction while the 5’-pRNA region was not 
(Figure 4D, right panel). We conclude that pRNA mediates the association of 
TIP5 with TTF1 and that unprocessed IGS-rRNA prevents this interaction. Based 
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on these results, we propose that the impairment of IGS-rRNA processing and the 
consequent lack of mature pRNA in ESCs abolishes the interaction of TIP5 with 
TTF1, thus preventing TIP5 targeting to rDNA and inhibiting formation of nucleolar 
heterochromatin.  
 
The epigenetic state of nucleolar chromatin affects ESC chromatin and 
pluripotency  
Clustering of heterochromatin at nucleoli is a phenomenon known to occur in 
many different organisms and cell types, yet neither the factors involved nor its 
physiological relevance is well understood. Recently, we showed that NIH3T3 
cells depleted of TIP5 displayed loss of heterochromatin at both rDNA and major 
and minor satellites, suggesting a crosstalk between nucleolar and nuclear 
heterochromatin that is mediated by TIP5 (Guetg et al., 2010). Remarkably, 
somatic cells depleted of TIP5 and ESCs display similar nuclear architecture 
features such as the enlargement of nucleolar surfaces, the reduction of nucleoli 
number and the formation of few decondensed heterochromatic foci (Figure 5A). 
To determine whether the epigenetic state of rRNA genes affects the open 
chromatin structure of ESCs, we analyzed the effects of pRNA-mediated rDNA 
specific targeting for heterochromatin formation on H3K9me3 and H3K9me2 
levels at major and minor satellites, LINE L1 elements and IAP LTR transposons 
(Figure 3D, Figure S2). ESCs+pRNA increased H3K9me2 levels not only at 
rDNA but also at major and minor repeats and at LINE elements while IAP LTR 
transposons were not significantly affected. H3K9me3 levels drastically increased 
at both minor and major satellites while remaining unchanged at rDNA, LINE L1 
elements and IAP LTR transposons. Among the four experiments we performed, 
3 Results 
 
 
 
67 
we observed an inverse correlation in the enrichment between H3K9me2 and 
H3K9me3 levels at minor and major repeats (Figure S2), suggesting a two-step 
process that initiates with H3K9me2 (that is the activity brought to rDNA by TIP5 
(Santoro and Grummt, 2005)) and which is further completed with the 
establishment of trimethylation at H3K9. Consistent with this, ESCs+pRNA 
increased the total amount of H3K9me2 to levels similar to those observed during 
ESC-NPC transition (Figure 5B), a result in agreement with a previous work 
showing acquisition of large region of the H3K9me2 during differentiation which 
affects at least 30% of the genome (Wen et al., 2009). In contrast, NPCs and 
ESCs+pRNA did not alter global H3K9me3 content when compared to ESCs. The 
increased heterochromatic content of ESCs+pRNA was also accompanied by a 
reduction of transcript levels of major and minor satellites, while transcription of 
LINE and IAP elements were not greatly affected (Figure 5C). We also observed 
a strong DAPI staining around and within many of the nucleoli occupied by TIP5 in 
ESCs+pRNA (Figure 3A), suggesting that AT-rich heterochromatin (including 
major and minor satellite) alters its structural organization upon pRNA-driven 
formation of rDNA heterochromatin in ESCs. Taken together, these results 
suggest that pRNA-mediated targeting of heterochromatin at rDNA in ESCs 
initiates a structural remodelling toward a highly condensed nuclear 
heterochromatin, a structure that ESCs normally acquire during differentiation.  
We next analyzed whether the increased heterochromatic content mediated by 
pRNA affects ESC properties. Transfection of pRNA in ESCs did not alter 
important molecular features of the undifferentiated state such as cell proliferation, 
expression of the pluripotency genes Oct4 and Nanog, cell morphology and 
alkaline phosphatase (AP) staining (Figure 6A-C, and data not shown). To 
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determine whether addition of pRNA affects pluripotency in vivo, we performed 
teratoma formation assay and assessed for the presence of tissues derived from 
all three-germ layers (Zhang et al., 2008). As shown in Figure 6D, ESCs+pRNA 
were no longer pluripotent because they lost the capability to form teratoma while 
control cells displayed teratomas consisting of derivatives of the three germ layers 
(Figure S4). To get insights into the loss of pluripotency, we analyzed 
transcription profiles of ESCs transfected with RNA-control and pRNA sequences 
by RNAseq and found upregulation of 529 transcripts and downregulation of 509 
transcripts in ESCs+pRNA (Table S1). We carried out functional annotation 
analysis with the DAVID tools (Huang et al., 2009) of transcripts whose levels 
were altered in ESCs+pRNA (Figure 6E; Table S1). The top 8 Gene Ontology 
(GO) terms were all related to cell developmental and differentiation processes. 
Enrichment for these processes was particularly evident for transcripts 
upregulated in ESCs+pRNA when compared to control cells, suggesting that 
addition of pRNA promotes expression of genes involved in cell differentiation and 
developmental processes. Together, these results indicate that the elevated 
heterochromatic content induced by formation of nucleolar heterochromatin 
through pRNA impairs pluripotency and highlight the role of the nucleolus in the 
control of ESC chromatin plasticity that is required for the maintenance of the 
undifferentiated state.  
To further explore the role of nucleolar chromatin in ESCs, we analyzed the 
differentiation capacity of cells depleted of TIP5. ESCs were initially treated with 
siRNA-Control and siRNA-Tip5 for 3 days, leading to 50% reduction of TIP5 levels 
(Figure 7A,B). ESCs depleted of TIP5 proliferated less when compared to control 
cells but displayed similar expression levels of the pluripotency markers Oct4, 
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Nanog and Rex1, exhibited the typical cell morphology of ESCs and were positive 
for AP staining  (Figure 7B-E). Similar results were obtained with other siRNA-
TIP5 sequences (data not shown), suggesting that TIP5 might play additional 
roles in ESCs which are not linked to the nucleolus and to pluripotency, an issue 
that is currently under investigation in our laboratory. To determine whether TIP5 
depletion affects ESC differentiation, we treated again an equal number of siRNA-
control and -Tip5 treated ESCs with their respective siRNAs and we induced 
monolayer differentiation upon withdrawal of 2i and LIF (Figure 7A). After 3 days, 
control cells displayed morphological structures typical of differentiated cells while 
cells depleted of TIP5 underwent cell death and detached from the plate (Figure 
7F-H). The majority of the few siRNA-TIP5 cells that remained attached to plates 
showed ESC-like structures and were positive for AP staining (Figure 7G,H, 
Figure S5). The effects observed with TIP5 depletion were specific for 
differentiated cells since ESCs double-treated with siRNA-Tip5 and cultured in LIF 
containing medium did not show any defect in viability (data not shown). These 
results indicate that TIP5 is required for viability of ESCs induced to differentiate 
and suggest that the establishment of nucleolar heterochromatin is a required 
event for early differentiation. 
 
 
Discussion 
In this work, we determined that the epigenetic state of nucleoli, at rRNA genes, in 
ESCs and during ESC differentiation (1) depends on processing of pRNA-
precursor IGS-rRNA, (2) regulates ESC nuclear architecture and chromatin 
plasticity, and (3) is implicated in the maintenance of pluripotency.  
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The epigenetic state of nucleolar chromatin regulates nuclear architecture 
and pluripotency of ESCs 
The spatiotemporal organization of genomes in the nucleus is an emerging key 
player to regulate genome function. For instance, the remodelling of the open and 
transcriptional permissive chromatin of ESCs toward a highly condensed 
heterochromatic form characterizes the exit from pluripotency and the progression 
into differentiated states. We determined here that the nucleolus is not only the 
place where ribosomes are produced but it also plays a role in nuclear 
architecture and pluripotency by regulating heterochromatic structures elsewhere 
in the genome. Using mature pRNA as a means to specifically tether 
heterochromatin at nucleoli of ESCs, we showed that the formation of 
heterochromatin within nucleoli, at rRNA genes, has the ability to signal and to 
initiate the establishment of repressive chromatin structures at regions of the 
genome located outside of the nucleolus like it is found in differentiated cells. The 
remodelling into heterochromatic structures induced by ectopic pRNA in ESCs is 
also evidenced by a global increase in H3K9me2, the maturation of 
heterochromatin at repetitive sequences and their transcriptional repression, all 
features characterizing the ESC differentiation process (Efroni et al., 2008; Wen et 
al., 2009). Although showing some of the molecular outlines of the 
undifferentiated cells, such heterochromatic ESCs transcribe genes implicated in 
differentiation processes and are not longer pluripotent, underscoring the role of 
the euchromatic organization in ESC functions and suggesting that nucleolar 
chromatin is an important regulator of the pluripotent state. Although we cannot 
define which is the first event that globally initiates the formation of 
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heterochromatin at the exit from pluripotency and entry into differentiation, our 
results place the nucleolus as an important regulator of this process. First, the 
establishment of rDNA heterochromatin during differentiation coincides with the 
formation of highly condensed heterochromatic structures and LOCKs (Meshorer 
and Misteli, 2006; Wen et al., 2009). This was particularly evident for the 
maturation of constitutive heterochromatin at major and minor satellite repeats, 
which displayed the same timing of rDNA for the acquisition of histone repressive 
marks and transcriptional repression upon ESC differentiation. The crosstalk 
between these repeats is consistent with the positioning of H3K9me3 rich regions 
and clustering of centromeres around nucleoli, previously described to 
accompany changes in nuclear architecture during ESC differentiation (Bartova et 
al., 2008a; Wiblin et al., 2005). Second, targeting of heterochromatin at rDNA in 
ESCs induces heterochromatic changes and increases global H3K9me2 content 
at levels similar to those found in somatic cells, and leads to loss of pluripotency. 
Third, impairing the formation of rDNA heterochromatin by TIP5 knockdown 
inhibits ESC differentiation, suggesting that the establishment of nucleolar 
heterochromatin might be a necessary step for the switch from a lower to a higher 
order chromatin structure and exit from the undifferentiated state.   
The crosstalk between rDNA and nuclear repetitive sequences is also in line with 
recent data showing the loss of heterochromatin at both rDNA and major and 
minor satellites of somatic cells depleted of TIP5 (Guetg et al., 2010; Postepska-
Igielska et al., 2013). Because of the linear proximity of rDNA and centromeric 
sequences at rDNA-containing chromosomes (Dev et al., 1977; Kurihara et al., 
1994b), rDNA chromatin might affect the epigenetic states of centric and 
pericentric repeats through spreading mechanisms (i.e. from silent rRNA repeats 
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to adjacent centric-pericentric repeats). However, centromeres of chromosomes 
not containing rRNA genes were described to associate with the nucleolus at a 
frequency more than that expected for a random distribution (Carvalho et al., 
2001), implying an active anchoring of heterochromatic sequences at nucleoli that 
is independent on sequence position. In this case, the establishment of rDNA 
heterochromatin might allow the formation of a nucleolar/perinucleolar 
compartment enriched in chromatin repressor complexes that becomes attractive 
for genomic regions that have to be repressed. An important example is provided 
by the perinucleolar targeting of the inactive X that was implicated for the 
maintenance of its repressed epigenetic state (Zhang et al., 2007). In line with 
this, recent high-resolution sequencing of the nucleolus unraveled the presence of 
regions with low gene density and significantly enriched in transcriptional 
repressed genes (Nemeth et al., 2010; van Koningsbruggen et al., 2010). 
Therefore, anchoring of heterochromatin at the nucleolus might serve similar 
functions like the ones described for the nuclear periphery that is responsible for 
the integrity of mammalian heterochromatin (Pinheiro et al., 2012; Towbin et al., 
2012). Consistent with this, genomic regions localized at the lamina (LADs) after 
cell division were shown to relocate either at the lamina or at the nucleolus (Kind 
et al., 2013), suggesting interchangeable roles in regulating and maintaining 
heterochromatic states.   
The results described here also provided evidences that rRNA genes do not only 
function in synthesizing rRNA for ribosome production. Indeed, accumulating 
evidences suggested that the major task for the formation of silent rDNA 
heterochromatin is not to regulate rRNA transcription. Silent rRNA repeats, 
present in all somatic cells, maintain their chromatin and epigenetic state 
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independently of transcriptional activity and are stably propagated throughout the 
cell cycle (Conconi et al., 1989), a result in agreement with the many data 
showing that rRNA synthesis is regulated by modulating the activity of 
transcriptionally competent (active) genes and not by changing the number of 
silent genes (reviewed in (Santoro, 2012)). Our results indicated that the 
epigenetic state of rRNA genes contributes to nuclear architecture and cellular 
functions such as pluripotency and ESC differentiation by controlling the balance 
between heterochromatin and euchromatin. The relationship between nucleolar 
and nuclear chromatin is also supported by data showing that the maintenance of 
rDNA heterochromatin is required for genome stability. In the yeast S. cerevisiae, 
Drosophila and mouse cells disruption of rDNA heterochromatin instigates 
genome instability at the rDNA and satellite repeat arrays (Guetg et al., 2010; 
Mekhail et al., 2008; Peng and Karpen, 2007). In addition, rDNA deletions in 
Drosophila result in reduced heterochromatin-induced gene silencing elsewhere in 
the genome and the extent of the rDNA deletion correlates with the loss of 
silencing in much the same manner as mutations in known protein 
heterochromatin components (Paredes and Maggert, 2009).  
 
RNA processing modulates distinct functions of the same lncRNA  
Very little is understood about how specific lncRNAs seek out selective sites in the 
genome for interaction, and nature of lncRNA-chromatin interactions, and their 
possible functional roles in lncRNA biology (Rinn and Chang, 2012). This work 
underlined the role of lncRNA in targeting epigenetic regulatory processes at 
specific genomic loci leading to the establishment of chromatin conformation 
patterns that ultimately result in the fine control of genes (Costa, 2008). We 
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showed that the regulation of pRNA precursor IGS-rRNA processing is a key 
determinant for the control of the epigenetic state at rDNA and proposed that the 
processing represents a mean of ncRNA regulation to modulate distinct functions 
of the same ncRNA. We determined that IGS-rRNA processing is a regulated 
process and that its impairment in ESCs prevents recruitment of TIP5 to rDNA 
and formation of rDNA heterochromatin. Although the mechanisms that impair 
IGS-rRNA processing in ESCs are yet to be determined, our results demonstrated 
that the lack of mature pRNA abolishes the formation of rDNA heterochromatin in 
ESCs. Indeed, addition of pRNA in ESCs was sufficient to recruit TIP5 to rDNA 
and to establish rDNA repressive structures. We unravelled the molecular insights 
that distinguish the processed from the unprocessed pRNA and showed that while 
IGS-rRNA abolishes the association of TIP5 with TTF1, pRNA promotes this 
interaction that serves to guide the complex to rDNA and to establish nucleolar 
heterochromatin. Thus, the same ncRNA can prevent or promote protein complex 
assembly and its processing controls the switch to these functions. Although 
pRNA was recently proposed as an example of guiding of epigenetic regulators to 
specific genomic loci through RNA-DNA complementarity such as triple helix 
(Bierhoff et al., 2013; Schmitz et al., 2010), our results do not support this model 
but favour a pRNA-mediated targeting of TIP5 through DNA-protein recognition 
rules that is further regulated by processing. Whether triple-helix pRNA is 
implicated in other physiological processes it remains an issue to be further 
investigated.  
Based on our results describing the mechanistic insights and functional 
consequences of pRNA processing in epigenetic and chromatin processes, it 
would not be surprising if processing emerges as a more general mechanism of 
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lncRNA regulation. 
  
In summary, our data underline the role of lncRNA processing in the regulation of 
epigenetic-mediated processes and the contribution of chromatin structure in ESC 
pluripotency and differentiation potential, and indicate that the epigenetic state of 
nucleolar chromatin is a key regulator of nuclear architecture and chromatin 
plasticity which serves to control cell pluripotency and lineage commitment. 
 
Experimental Procedures 
Experimental Procedures are described in Supplemental Experimental 
Procedures 
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Figure Legends 
Figure 1. Establishment of rDNA heterochromatin occurs during ESC 
differentiation and correlates with the recruitment of TIP5 to rDNA. 
(A) qRT-PCR. Nanog and Pax6 mRNA levels in ESCs and NPCs. Data were 
normalized to Rps12 mRNA.  
(B) CpG methylation levels at rDNA promoter in ESCs, NPCs and mouse brain 
tissues.  
(C) 45S pre-rRNA levels in ESCs, NPCs and NIH3T3 cells. rRNA levels were 
measured by qRT-PCR and normalized to Rps12 mRNA.  
(D) CpG methylation levels at rDNA promoter in mouse fibroblasts and iPSCs. 
(E) ChIP. H3K9me2, H3K9me3 and H3K27me3 occupancy at rDNA promoter and 
coding sequences, major and minor satellites and control genes Evx1. Data of two 
independent experiments were normalized to input and rDNA promoter value in 
ESCs. 
(F) ChIP. UBF, TIP5 and PARP1 occupancy at rDNA promoter and coding 
sequences. Zfpm2 and Gapdh represent control genes. Data of two independent 
experiments were normalized to input and rDNA promoter values in ESCs.  
(G) Tip5 mRNA (qRT-PCR) and protein levels (immunoblot) of ESCs and NPCs. 
Data were normalized to Rps12 mRNA or PARP1 protein levels. 
(H) TIP5 cellular localization in MEFs, ESCs and NPCs by immunofluorescence. 
Nucleoli are visualized by UBF signal.  
All error bars indicate the SD of two (when indicated) or three independent 
experiments. 
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Figure 2. IGS-rRNA is not efficiently processed in ESCs 
(A) Schema representing the mouse 5’-rDNA organization: Spacer promoter 
(grey), intergenic spacer region (blue), rDNA main promoter (Paredes and 
Maggert), and transcription start sites of IGS-rRNA (-1997) and 45S pre-rRNA 
(+1). Arrows represent primers used to perform RT (1; -20/-1) and to quantitatively 
amplify the indicated rDNA sequences (2-7). 
(B) Levels of 5’- and internal IGS-rRNA, and pRNA sequences of ESCs and NPCs 
(from days 2 to 6, from the beginning of differentiation) were measured by qRT-
PCR. Data of two independent experiments were normalized to Rps12 mRNA and 
to ESC values. Amplifications of reactions performed without reverse 
transcriptase are not shown because out of scale. 
(C) Left panel. Schema depicts the IGS-rRNA reporter plasmid. Black arrows 
represent primers used to perform RT (10) and to amplify plasmid sequences (8 
and 9; black lane). Blue and red arrows (2 and 6) indicate primers hybridizing to 
rRNA sequences as described in (A). Right panel. NIH3T3 and ES cells were 
transfected with IGS-rRNA reporter plasmid. Data from three experiments are 
represented as values of amplifications with primers 2 and 8 (IGS-rRNA) 
normalized to amplifications with primers 6 and 9 (IGS-rRNA+pRNA).    
 
Figure 3. Mature pRNA is required for the establishment of rDNA 
heterochromatin 
(A) Immunofluorescence with anti-TIP5 and anti-UBF antibodies in ESCs 
transfected with in vitro synthesized RNA-control, pRNA and pRNADT0. 
(B) rDNA promoter methylation in ESCs transfected with RNA-control, pRNA and 
pRNADT0. Error bars indicate the SD of three independent experiments. 
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(C) 45S pre-rRNA levels in ESCs transfected with RNA-control and pRNA. rRNA 
levels were measured by qRT-PCR and normalized to Rps12 mRNA. Error bars 
indicate the SD of two independent experiments. 
(D) Box-and-whisker plot of four independent ChIP experiments showing 
H3K9me2 and H3K9me3 association with the rDNA promoter, minor and major 
satellite repeats, LINE and IAP-gag sequences. Data are represented as bound 
over input in ESCs+pRNA normalized to values measured in ESCs+RNA-control.  
(E) Immunofluorescence with anti-TIP5 and anti-UBF antibodies of ESCs 
transfected with the indicated pRNA mutants. 
 
Figure 4. pRNA mediates TIP5-TTF1 interaction 
(A) TIP5 binds to IGS-rRNA. Increasing equal moles of in vitro transcripts 
corresponding to control, pRNA and IGS-rRNA sequences were used to compete 
for binding of TIP5332-723 to radiolabelled run-off transcripts from pBluescript (MCS-
RNA). RNA/protein complexes were analyzed by EMSA. 
(B) TTF1 binds to RNA. Increasing equal moles of full length TTF1 and TIP5332-723 
were incubated with radiolabeled MCS-RNA. 
(C) TTF1 does not show preferential binding to pRNA. Increasing equal moles of 
RNA-control and pRNA were used to compete for binding of full length TTF1 to 
radiolabeled MCS-RNA. 
(D) TIP5-TTF1 interaction is mediated by pRNA and impaired by IGS-rRNA. 
Upper panel. Schema representing the GST-pull-down strategy used to analyze 
TIP5-TTF1 interaction in the presence of equivalent moles of RNAs. Lower panel. 
Pull-down assay. Bound proteins, GST, GST-TIP5 and His-TTF1, were detected 
with anti-GST and anti-His antibodies, respectively.  
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Figure 5. Mature pRNA induces global remodelling toward heterochromatic 
structures 
(A) Immunofluorescence representing heterochromatin (DAPI) and nucleoli (UBF) 
in NIH3T3 cells stably expressing shRNA-control and -Tip5 sequences, and 
ESCs.  
(B) Immunoblot of H3K9me2, H3K9me3 and histone H3 of chromatin fractions of 
ESCs, NPCs, ESCs+RNA-control and ESCs+pRNA. Values from two 
independent experiments were normalized to histone H3 levels. 
(C) qRT-PCR of major and minor satellite, LINE and IAP retrotrasposon 
transcripts in ESCs+RNA-control and ESCs+pRNA. Amplifications of reactions 
performed without reverse transcriptase are not shown because out of scale. 
Values from two independent experiments were normalized to Rps12 mRNA. 
 
Figure 6. pRNA impairs ESC pluripotency 
(A) Nanog and Oct4 mRNA levels in ESCs+RNA-control and ESCs+pRNA (qRT-
PCR). Values from two independent experiments were normalized to Rps12 
mRNA. 
(B) Cell morphology and (C) AP staining of ESCs+RNA-control and ESCs+pRNA.  
(D) ESCs+pRNA are not pluripotent. Efficiency of teratoma formation was 
assessed by number of teratomas generated vs. expected (injections). 
(E) Top eight biological process gene ontology terms as determined using DAVID 
for genes regulated, and up- and downregulated in ESCs+pRNA cells.   
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Figure 7. Depletion of TIP5 impairs ESC differentiation 
(A) Schema showing the experimental strategy for depletion of TIP5 in ESCs. 
(B) TIP5, Oct4, Nanog and Rex1 mRNA levels in ESCs depleted of TIP5. 
(C) TIP5 knockdown affects ESC proliferation. Data represents relative cell 
numbers after 3 days of siRNA treatment.   
(D) Cell morphology and (E) AP staining of ESCs treated with siRNA-control and -
Tip5. 
(F) Cell morphology and AP staining of cells after 3 days of differentiation. 
Quantifications are shown respectively in (G) differentiated (+), partially 
differentiated (+/-) and not differentiated (-) and (H) stained (+), partially stained 
(+/-) and not stained (-). 
(I) Model showing formation of rDNA heterochromatin in ESC differentiation and 
its influence in nuclear heterochromatin. IGS-rRNA is not processed in ESCs with 
consequent lack of mature pRNA. The unprocessed transcript impairs the 
association of TIP5 with TTF1, inhibiting recruitment to rDNA and formation of 
heterochromatin. Upon differentiation, IGS-rRNA is processed and generates 
pRNA that allows TIP5 to interact with TTF1 and to be recruited to rDNA. The 
arrow depicts the influence of rDNA heterochromatin in the formation of nuclear 
repressive chromatin structures. 
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Figure 4 
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Figure 6 
 
3 Results 
 
 
 
95 
 
Figure 7 
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Supplementary Figure S1 
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Supplementary Figure S2 Supplementary Figure S2
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Supplementary Figure S3 
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Supplementary Figure S4 
 
 Supplementary Figure S4
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The epigenetic state of the nucleolus regulates chromatin plasticity and 
pluripotency of embryonic stem cells  
Savic et al. 
 
Supplemental data 
 
Supplemental Figure legends 
Figure S1 (related to Figure 1B, 1E) 
(A) CpG methylation levels at rDNA promoter in ESCs (JM8N4) and during 
differentiation into NPCs. ESCs were cultivated on monolayer and differentiation 
was induced with N2B27 medium supplemented with RA. Error bars indicate the 
SD of two independent experiments. 
(B) ChIP. H3K9me2 and H3K9me3 occupancy at rDNA promoter and coding 
sequences, major and minor satellites and control genes Evx1 monitored during 
different time points (days) of differentiation. Data were normalized to input and 
rDNA promoter values in ESCs. 
(C) Major and minor satellite transcript levels in ESCs and NPCs were measured 
by qRT-PCR and normalized to Rps12 mRNA. Error bars indicate the SD of two 
independent experiments. 
 
Figure S2 (related to Figure 3D) 
(A) Scatter plot of the four ChIP experiments shown in Figure 3D.  
(B) Results of the single four ChIP experiments showing an inverse correlation in 
the enrichment between H3K9me2 and H3K9me3 levels at minor and major 
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repeats in ESCs+pRNA when compared to ESCs+RNA-control.  Data are 
represented as bound over input in ESCs+pRNA normalized to values measured 
in ESCs+RNA-control.  
 
Figure S3 (related to Figure 4) 
(A) TIP5 binds to IGS-rRNA and it has a stronger affinity for pRNA sequences. 
Increasing equal moles of in vitro transcripts corresponding to pRNA, spacer 
promoter and enhancer repeat RNA were used to compete for binding of TIP5332-
723 to radiolabelled run-off transcripts from pBluescript (MCS-RNA). RNA/protein 
complexes were analyzed by EMSA. 
(B) TTF1 binds to the rDNA promoter of ESCs. ChIP showing association of TTF1 
with rDNA promoter in ESCs and NIH3T3 cells. Data of two independent 
experiments were normalized to input and rDNA promoter values. The low levels 
of TTF1 association with +8 Kb rDNA sequences (that do not contain T elements) 
demonstrated the specificity of the assay.   
 
Figure S4 (related to Figure 6D) 
Histological analysis of teratomas revealed that ESCs differentiate into all three 
germ layers as shown by the presence of ectoderm (A, B, D), endoderm (C) and 
mesoderm (E,F). A, C, E haematoxylin staining. Immunostaining for bIII tubulin 
(TuJ1) (B), glial fibrillary acidic protein (GFAP) (D) and smooth muscle actin 
(SMA) (F). Inserts show higher magnification. Scale bars, 100 µm.  
 
Figure S5 (related to Figure 7F,G) 
(A) Cell morphology and (B) AP staining of differentiated ESCs treated with 
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siRNA-control and -Tip5. 
  
Supplemental Table legends 
 
Supplemental Table S1 (related to Figure 6E) 
Total RNA of ESCs+Control-RNA and ESCs+pRNA from two biological replicates 
were purified and analyzed by RNA seq. The table includes the list of genes 
whose transcript levels were altered in ESCs+pRNA when compared to control 
cells (defined as regulated, upregulated and downregulated) and gene onthology 
analysis using DAVID tools. 
 
Supplemental Table S2 (Related to Experimental Procedures) 
List of primers used for amplification in ChIP and RT-PCR analyses 
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Experimental procedures  
 
 mESC culture 
129 mouse embryonic stem cells (E14 line) were cultured in N2B27 media (D-
MEM F12, Neurobasal medium, N2/B27 supplements, 2mM L-glutamine with 
Pen/Strep, β-Mercaptoethanol) supplemented with recombinant leukemia 
inhibitory factor, LIF (ESGRO, 1000 U/ml) and MEK and GSK3β inhibitors, 2i 
(Stemolecule CHIR99021 and PD0325901, 3µM and 1µM respectively). Cells 
were seeded at a density of 50,000 cells/cm2 in culture dishes (Corning® 
CellBIND® surface) treated with 0.1% Gelatine without feeder layer. Propagation 
of cells was carried out every 2 days using Trypsin 0.5x for enzymatic cell 
dissociation. 
 
mESC differentiation 
mESCs were differentiated to neural progenitor cells according to previously 
established protocol (Bibel et al., 2004). In brief, differentiation employed a 
suspension-based embryoid bodies formation (Bacteriological Petri Dishes, Bio-
one with vents, Greiner®). The neural differentiation media (D-MEM, 10% FCS, 
1xMEM NEAA, 2mM L-glutamine with Pen/Strep, β-Mercaptoethanol) was filtered 
trough 0.22µm filters and stored at 4°C.  During the 8-day differentiation 
procedure media was exchanged every 2 days. In the last 4 days of differentiation 
the media was supplemented with 2 µM retinoic acid (RA) to generate neural 
precursors that are Pax-6-positive radial glial cells.  
 
 
3 Results 
 
 
 
105 
Transfections 
ESCs were seeded at a density of 20,000 cells/cm2 and transfected with the 
indicated siRNAs (50 nM siRNA) or synthetic RNAs (1 mg/ml) using 
Lipofectamine® RNAiMAX (Life Techonlogies) in Opti-MEM® GlutaMAX™ 
(GIBCO) reduced-serum medium. Analysis of differentiated transfected ESCs was 
performed using consecutive transfections. Three days after the first transfection, 
equal amounts of ESCs (e.g. siRNA-control and siTIP5 treated cells) were again 
transfected and induced to differentiate in complete media (G-MEM, 10%FCS, 
Sodium Pyruvate 100mM, 1xMEM NEAA, L-Glutamine) by withdrawal of LIF and 
2i. Efficiencies of siRNA-mediated depletions and synthetic RNA levels were 
monitored by qRT-PCR 3-4 days post-transfection. 
 
In Vitro Transcription 
The indicated pRNA and control sequences were cloned by PCR into pJET1/2 
plasmids. pRNA : mrDNA from -232 to -1; Control-pRNA: control sequences at 5’, 
mrDNA from -140 to -1 at 3’; pRNA-Control: mrDNA from -232 to -140 at 5’, 
control sequences at 3’ ; pRNA-loop destroyed: mrDNA from -232 to -1 
sequences where GGG (-115/-113) were replaced with AAA; pRNA-loop 
recovered: mrDNA from -232 to -1 sequences where CCC (-60/-58) were replaced 
with TTT. All plasmids were verified by sequencing. Synthetic RNAs were 
synthesized using T7 polymerase and as substrate Xba I linearized pJET1/2 
vectors containing the indicated sequences. After treatment with DNase I, 
transcripts were double purified using TRIzol reagent (Invitrogen) according to the 
manufacture’s protocol.  
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Indirect immunofluorescence 
ESCs or differentiated cells were grown on gelatin-coated coverslips and 
permeabilized with 0.05% Triton X-100 in 20mMTris-HCl, pH 8, 5mM MgCl2, 
0.5mM EDTA, and 25% glycerol. After washing, cells were fixed with cold 
methanol (7 min) and stained with anti-TIP5 (Diagenode) and anti-UBF 
(SantaCruz) antibodies and DAPI (Molecular Probes), and immunofluorescent 
images were digitally recorded. 
 
Chromatin Immunoprecipitation 
The chromatin immunoprecipitation (ChIP) protocol was previously described 
(Santoro, 2014). Briefly, formaldehyde 1% was added to cultured cells to cross-
link proteins to DNA. Isolated nuclei were then lysed in 300µl lysis buffer (50 mM 
Tris-HCl [pH 8.1], 10 mM EDTA, 1% SDS) and sonicated using a Bioruptor 
ultrasonic cell disruptor to shear genomic DNA to an average fragment size of 
200bp. 20 to 40 mg chromatin was diluted tenfold with IP buffer (16.7 mM Tris-
HCl [pH 8.1]), 167 mM NaCl, 1.2 mM EDTA, 0.01% SDS, 1.1% Triton X-100) and 
than immunoprecipitated overnight with ChIP-grade antibodies. After elution and 
reversion of crosslinks, the precipitated DNA was purified with phenol/chloroform, 
ethanol precipitated and than quantified by qPCR. rDNA, major and minor satellite 
sequences were amplified with previously reported primers (Martens et al., 2005) 
(Martens et al., 2005; Santoro et al., 2002). Primers are listed in Table S2.   
 
RNA Extraction, reverse transcription and quantitative PCR (RT-qPCR)  
RNA was purified with Trizol reagent (Life Technologies) . Residual contaminating 
genomic DNA was removed with Ambion® TURBO™ DNase according to 
3 Results 
 
 
 
107 
manufacture’s instructions. RNA was primed with random hexamers and reverse-
transcribed to first-strand cDNA. Reverse transcription of pRNA and IGS-rRNA 
was performed using DNA oligo -20/-1 Rev or random primers. qRT-PCR was 
performed with SensiMix SYBR Hi-ROX Mix (Bioline) on a Rotor-Gene Q 
(Qiagen). Amplification of samples without reverse transcriptase assured absence 
of DNA (data not shown). The relative transcription levels were determined by 
normalizing to Rps12 mRNA levels. Statistical significance (P-values) of the 
difference in expression levels between genes was calculated using the two-
sample paired t-test. Primer sequences used in qRT-PCR are listed in Table S2. 
 
CpG methylation 
rDNA CpG methylation was measured as previously described (Santoro, 2014; 
Santoro et al., 2002)). 2 mg genomic DNA were digested with HpaII (NEB) in the 
presence of 5 ng of unmethylated pBluescript KS(+) plasmid. rDNA CpG 
methylation levels were measured by quantitative amplification using primer pairs 
(-165/-145 Forw and -20/-1 Rev) that flank the restriction sites CCGG at -142 of 
rDNA promoter or primers that amplify neighbouring sequences lacking HpaII 
sites (+1/+20 Forw and +111/+130 Rev). Values were obtained using  logarithmic 
dilutions of mouse genomic DNA as standard curve. CpG methylation levels were 
calculated as resistance to HpaII digestion by normalizing the amounts of rDNA 
amplified from -165 to -1 to the levels of amplicons from +1 to +130. To verify 
HpaII digestion efficiency, pBluescript KS(+) plasmid was analyzed by qPCR 
using one forward primer that is complementary to sequences upstream of the 
CCGG site of b-lactamase gene (at 2580) and two different reverse primers that 
map upstream and downstream the HpaII sites (see Table S2). All analyzed 
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samples displayed 96-98% digestion efficiency. 
 
EMSA   
Radiolabeled MCS-RNA was synthesized by T7 RNA polymerase using 
pBluescript-KS(+)/EcoRI as template. After treatment with DNase I, transcripts 
were purified and 50,000 cpm of MCS-RNA were incubated for 15 min on ice with 
40 ng recombinant TIP5 or TTF1 in EMSA buffer (20 mM Tris-HCl [pH 8.0], 5 mM 
MgCl2, 100 mM KCl, and 0.2 mM EDTA). Cold competitor RNA was added, and 
incubation was continued for 30 min. RNA-protein complexes were analyzed by 
electrophoresis on 6% (w/v) native polyacrylamide gels and visualized by 
autoradiography. 
 
GST-Pulldown 
5 µg of GST-TIP5235-741 were incubated with 15µl of GST beads (Glutathione 
Sepharose 4B, GE Healthcare) in AM100 buffer (100mM KCl, 20mM Tris-HCl pH 
8.0, 5mM MgCl2, 0.2mM EDTA, 1X Protease Inhibitor (Roche)) for 12-16 hours at 
4°C. After two washes with EMSA buffer containing 3% Glycerol, bound GST-
TIP5235-741 was incubated with 25 nmoles of the indicated RNAs for 1h at 4°C. 
After a double wash with AM200 buffer (200mM KCl, 20mM Tris-HCl pH 8.0, 5mM 
MgCl2, 0.2mM EDTA, 1X Complete Protease Inhibitor Cocktail (Roche)), bound 
GST-TIP5/RNA complexes were incubated with 0.5 µg of His-TTF11-210 for 2h at 
4°C. Samples were then washed three times with EBC buffer (250mM NaCl, 
50mM Tris-HCl pH8.0, 0.5% NONIDET P-40, 5mM DTT, 1X cOmplete Protease 
Inhibitor Cocktail), run on a 12% SDS polyacrylamide gel and analyzed by 
Western blot with anti-GST and anti-RGS.HIS antibodies. 
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AP staining 
Cells were fixed in 4% paraformaldehyde for 10min, washed with AP Buffer 
(100mM TrisCl pH 9.5, 100mM NaCl, 50mM MgCl2) and then incubated for 30 
min in AP Buffer containing NBT (37 mg/ml) and 3.5µl BCIP (175 mg/ml). The 
staining was blocked with Tris-EDTA (Sigma) for 10min. 
 
Whole-Transcriptome Shotgun Sequencing (RNA-Seq) and Data Analyses  
Total RNA of ESCs+Control-RNA and ESCs+pRNA from two biological replicates 
were purified and analyzed by RNA seq. 100bp paired-end reads have been 
sequenced with illumina Hiseq. The reads were quality filtered and submitted to 
RSEM for expression quantitation (Li and Dewey, 2011). Expression counts were 
further analyzed with the glm method in the edgeR package to compute the 
significance of differential expression (Robinson et al., 2010). 
 
Teratoma analysis  
Teratoma samples were fixed in 4% buffered paraformaldehyde and embedded in 
paraffin. For immunostainings, 5 µm thickness paraffin sections were 
deparaffinized and rehydrated and subsequently subjected to the antigen retrieval 
(Citrate buffer pH 6.0 for 10 minutes at 110°C in rapid microwave histoprocessor, 
Milestone, USA). The following primary antibodies were used: anti-bIII tubulin 
(Sigma), anti-GFAP (DAKO) and anti-SMA (Sigma). Nuclei were stained with 
DAPI and slides were mounted with Fluorescent Mounting Medium (DAKO) to 
avoid bleaching. Images were captured with a Leica DMI 6000B Microscope and 
using LAS AF (Leica Application Suite Advanced Fluorescence) software. Animal 
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experiments were performed in accordance with Swiss law and have been 
approved by the veterinary authorities of Zurich.  
 
Antibodies  
The following antibodies were used: anti-TIP5 (CS-090-100-Diagenode); anti-UBF 
(sc-13125), anti-GST (sc-459) and anti-PARP1 (sc-53643) from Santa Cruz; anti-
H3K9me2 (17-648), anti-H3K9me3 (17-625), and anti-H3K27me3 (17-622) from 
Millipore; anti-H3 (ab1791) from Abcam; anti-RGS.HIS (34610) from Qiagen. Anti-
TTF1 antibody was produced with Genosphere. 
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Table S2  
List of primers 
 
mouse rDNA CpG methylation primers 
Name For/Rev Sequence 
rDNA promoter  -165/-145 For GACCAGTTGTTCCTTTGAGG 
rDNA promoter  -21/-1 Rev ACCTATCTCCAGGTCCAATAG 
rDNA coding  +1/+20 For ACTGACACGCTGTCCTTTCC 
rDNA coding  +111/+130 Rev GACAGCTTCAGGCACCGCGA 
 
 
mouse cDNA primers 
Name For/Rev Sequence 
Tip5  For AAGATGTGTGGCTACAATGG  
Tip5  Rev TCTGCACCCATCAGCTCCG 
Nanog  For AAGCAGAAGATGCGGACTGT 
Nanog Rev ATCTGCTGGAGGCTGAGGTA 
Pax6 For GCACATGCAAACACACATGA 
Pax6 Rev ACTTGGACGGGAACTGACAC 
Minor satellites For CATGGAAAATGATAAAAACC 
Minor satellites Rev CATCTAATATGTTCTACAGTGTGG 
Major satellites For GACGACTTGAAAAATGACGAAATC 
Major satellites Rev CATATTCCAGGTCCTTCAGTGTGC 
rDNA spacer -1994/1975 For GCAGACCGAGTTGCTGTAC 
3 Results 
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rDNA spacer -1922/1905  Rev GGGTAGGACTTAAGCCTT 
rDNA enhancer -554/-535 For GAAGCCCTCTTGTCCCCGTC 
rDNA enhancer -466/-447 Rev GATCCAAAGCTCCAGCTGAC 
rDNA promoter -165/-145  For GACCAGTTGTTCCTTTGAGG 
rDNA promoter -21/-1 Rev ACCTATCTCCAGGTCCAATAG 
45S pre-rRNA +550/570 For CTCTTGTTCTGTGTCTGCC 
45S pre-rRNA +745/765 Rev GCCCGCTGGCAGAACGAGAAG 
Line L1 ORF2  For TTTGGGACACAATGAAAGCA 
Line L1 ORF2 Rev CTGCCGTCTACTCCTCTTGG 
IAPgag  For AGCAGGTGAAGCCACTG 
IAPgag  Rev CTTGCCACACTTAGAGC 
Oct-4 For GGCGTTCGCTTTGGAAAGGTGTTC 
Oct-4 Rev CTCGAACCACATCCTTCTCT 
Rex1 For AGAAAGCAGGATCGCCTCAC 
Rex1 Rev AGGGAACTCGCTTCCAGAAC 
Rps12 For GAAGCTGCCAAAGCCTTAGA 
Rps12 Rev AACTGCAACCAACCACCTTC 
Gapdh For TGCACCACCAACTGCTTAGC 
Gapdh Rev GGCATGGACTGTGGTCATGAG 
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ChIP primers 
Name For/Rev Sequence 
rDNA promoter  -165/-145 For GACCAGTTGTTCCTTTGAGG 
rDNA promoter  -21/-1 Rev ACCTATCTCCAGGTCCAATAG 
rDNA  coding +2251/70 For GCATCGGTGTGTCGGCATCG 
rDNA  coding +2346/65 Rev CTGAGCAGTCCCACCACACC 
rDNA  coding  +8124/145 For GCGACCTCAGATCAGACGTGG 
rDNA  coding  +8203/224 Rev CTGTTCACTCGCCGTTACTGAG 
Minor satellites For CATGGAAAATGATAAAAACC 
Minor satellites Rev CATCTAATATGTTCTACAGTGTGG 
Major satellites For GACGACTTGAAAAATGACGAAATC 
Major satellites Rev CATATTCCAGGTCCTTCAGTGTGC 
Evx1 promoter For TACACAGCATCTGGGGAGTG 
Evx1 promoter Rev GTGTGCTGGGTTAAGGGAGA 
Gapdh promoter For GGTTGCTGTGTCACTACCGAAGAA 
Gapdh promoter Rev AAATGGAGAAGTGTGGGTCTCCCT 
Line L1 ORF2  For TTTGGGACACAATGAAAGCA 
Line L1 ORF2 Rev CTGCCGTCTACTCCTCTTGG 
IAPgag  For AGCAGGTGAAGCCACTG 
IAPgag  Rev CTTGCCACACTTAGAGC 
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ABSTRACT
ADP-ribosyltransferases (ARTs) are important
enzymes that regulate the genotoxic stress
response and the maintenance of genome integrity.
ARTD1 (PARP1) and ARTD2 (PARP2) are homologous
proteins that modify themselves and target proteins
by the addition of mono- and poly-ADP-ribose (PAR)
moieties. Both enzymes have been described to be
involved in the genotoxic stress response. Here, we
characterize cellular PAR formation on hydrogen
peroxide (H2O2) or N-methyl-N0-methyl-nitro-N-
nitrosoguanidine (MNNG) stress, in combination
with application of the RNA polymerase I inhibitor
Actinomycin D (ActD), known to cause accumulation
of short RNA polymerase I-dependent rRNA
transcripts. Intriguingly, co-treatment with ActD
substantially increased H2O2- or MNNG-induced
PAR formation. In cells, this enhancement was
predominantly mediated by ARTD2 and not ARTD1.
In vitro experiments confirmed that ARTD2 is
strongly activated by RNA and that the N-terminal
SAP domain is important for the binding to RNA.
Thus, our findings identify a new activator of
ARTD2-dependent ADP-ribosylation, which has
important implications for the future analysis of the
biological role of ARTD2 in the nucleus.
INTRODUCTION
Cells have evolved a complex and diverse arsenal of
mechanisms to overcome genotoxic stress and to guaran-
tee genome integrity (1). Depending on the type of stress,
different response mechanisms are activated to repair
damaged DNA or to prevent its inheritance (2,3). In
addition to factors that directly bind and replace incorrect
bases and repair DNA strand breaks, a variety of proteins
are indirectly involved in the genotoxic stress response by
regulating the levels and activities of other proteins or by
modulating chromatin structure. ADP-ribosyltransferases
(ARTs) are prominent members of this group of enzymes.
ARTs use nicotinamide adenine dinucleotide (NAD+)
as a substrate for the synthesis of mono- and poly-
ADP-ribose modifications on target proteins (4). The
ART protein family is divided into diphtheria toxin-like
ARTs (ARTDs) and cholera toxin-like ARTs (ARTCs)
(5). In humans, the ARTD (PARP) family currently
comprises 18 nuclear and cytoplasmic mono- and poly-
ARTs, while ARTCs are mainly extracellular enzymes
that only transfer a single ADP-ribose unit to their
target proteins (5).
Proteins of the ARTD family have been implicated in a
plethora of cellular functions (6,7). Research during the
past years has documented numerous functions of
ARTD1 (PARP1) and of ADP-ribosylation in general
that are not directly linked to DNA repair or the DNA
damage response (8,9). The function of ARTD1 in DNA
repair is substantiated by the strong activation of ARTD1
activity by DNA in vitro, as well as by the strong induction
of poly-ADP-ribosylation on treatment of cells with
DNA-damaging agents. Nevertheless, a direct involve-
ment of DNA damage in the activation of ARTD1
in vivo is still largely based on correlations. PAR forma-
tion is dependent on the severity of the genotoxic stress
and can even lead to cell death due to depletion of NAD+
and ATP (10). The functional involvement of ADP-
ribosylation in the DNA damage response has provided
the incentive to generate PARP inhibitors as antitumor
drugs, which are being developed and tested as novel
therapies (11–14). The closest homolog of ARTD1 is
ARTD2 (PARP2), which too is able to mono- and poly-
ADP-ribosylate itself in addition to target proteins.
Although ARTD1 has already been discovered several
decades ago, ARTD2 was coincidentally discovered
much later in the 1990s because of the detection of
residual PAR-forming activity in mouse embryonic fibro-
blasts (MEFs) from ARTD1 knockout mice (15). Like
ARTD1, ARTD2 has also been implicated in various
cellular functions, which include genome and chromosome
stability, heterochromatin integrity, cell death, differenti-
ation and inflammation (16). Mammalian ARTD2 is a
66.2-kDA protein with a C-terminal catalytic domain
that is 69% similar to the homologous domain in
ARTD1 (15,17). Despite this common domain, ARTD2
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is catalytically much less active than ARTD1, suggesting
that ARTD2 may become activated by different and as yet
unknown stimuli. While the DNA binding domain of
ARTD1 contains two Zn fingers and a Zn-binding
domain, the DNA binding element of ARTD2 is repre-
sented by the SAF-A/B, Acinus and PIAS DNA-binding
(SAP) domain. Furthermore, ARTD2 seems to modify
different proteins, suggesting that both enzymes might
regulate distinct biological functions (18,19). Thus, the
identification of such new ARTD2 activators will likely
also reveal novel biological phenomena that are regulated
specifically by ARTD2.
Nucleoli are sites of ribosomal RNA (rRNA) gene tran-
scription, rRNA maturation and ribosome production,
and assemble around the nucleolar organizer regions
(20,21). A human diploid cell contains !400 rRNA
genes, which are all organized in head-to-tail tandem
repeats on five different chromosomes (21). However, as
in highly metabolically active cells, only a subset of these
genes is actively transcribed (22,23). The remaining rRNA
genes are silenced in a tissue- and cell type-specific manner
(24). Active rRNA genes are transcribed by RNA poly-
merase I (Pol I) to synthesize a 45S pre-rRNA. For the
initiation of rRNA transcription, Pol I has to be part of a
multi-protein complex that includes factors such as UBF,
SL1 and TIF-IA (25). The production of ribosome
subunits is heavily influenced by diverse stress stimuli
and metabolic changes (26). The cell reacts to nutrient
starvation, oxidative stress or inhibition of protein synthe-
sis with a decrease of rRNA transcription, whereas growth
factors and proliferation-stimulating agents increase
rRNA transcription. Actinomycin D (ActD) inhibits
rRNA synthesis already at low concentrations (50 ng/
ml), whereas RNA polymerases II (Pol II) and III (Pol
III) are inhibited only at higher concentrations (Pol
II> 1 mg/ml, Pol III> 5 mg/ml) (27,28). ActD intercalates
into CG-rich regions of the DNA, and thus stabilizes
covalent topoisomerase I-DNA complexes, preventing
progression of RNA polymerase, thereby inhibiting
RNA synthesis (29). The intercalation mainly takes
place downstream of rDNA transcription start sites,
thus inhibiting transcription during elongation, which
leads to an immense accumulation of short RNA
transcripts over time (30,31). In Drosophila, ARTD1 has
been reported to regulate ribosomal biogenesis at the
posttranscriptional pre-rRNA processing level (32).
Furthermore, ARTD1 and ARTD2 have both been
shown to co-localize with B23/nucleophosmin and
nucleolin, nucleolar proteins involved in several processes
including rRNA transcription and elongation, ribosome
assembly and rRNA processing (33,34). However, no
direct effect of ARTD1 and ARTD2 on Pol I
transcription was described in these studies. More
recently, ARTD1 has been linked to heterochromatin
formation, specifically to silencing of rRNA genes in the
nucleolus (35,36).
Here, we characterize the nucleolar function of ARTD2
on different stresses. Hydrogen peroxide (H2O2) or
N-methyl-N’-methyl-nitro-N-nitrosoguanidine (MNNG)
treatment of different cell lines induced PAR formation
in the nucleolus. Co-treatment with low doses of ActD
enhanced PAR formation. Surprisingly, this co-treatment
mainly activated ARTD2. In vitro experiments confirmed
that ARTD2 is strongly activated by short rRNA and
other single-stranded RNAs, but not by double-stranded
DNA, through its SAP domain. Thus, our findings reveal
a new activator of ARTD2, which opens new possible
implications for the future analysis of the biological role
of ARTD2.
MATERIALS AND METHODS
Cell culture
T24 bladder tumor cells were cultivated in McCoy’s 5A
medium (Gibco, Invitrogen, CA, USA) at 37"C. NIH/
3T3, HeLa cells and MEFs were cultivated in
Dulbecco’s modified Eagle’s medium (PAA, Pasching,
Austria). MD-MBA-231 cells were cultivated in Roswell
Park Memorial Institute medium (Gibco, Invitrogen, CA,
USA). All media were supplemented with 1% (v/v)
Penicillin/Streptomycin and 10% (v/v) fetal calf serum
(Gibco, Invitrogen, CA, USA).
siRNA transfection
Negative control allstars (siMock), human siPARP1
(SI02662996), human siPARP2 (SI02664725), human
siPARG (SI00677782), mouse siPARP1 (SI02731428)
and mouse siPARP2 (SI02735670) were all obtained
from Qiagen (Hilden, Germany). Cells were seeded 1
day before transfection (5# 105 cells per 6 cm plate) and
transfected with 40 nmol siRNA per plate and RNAi
MAX lipofectamine (Invitrogen, Carlsbad, CA, USA).
Antibodies
The following antibodies were used: from Santa Cruz
Biotechnology, Inc (Dallas, TX, USA): PARP1/ARTD1
(H-250, sc-7150, rabbit), Pol I (RPA 194, H-300, sc-28714,
rabbit). From Active motif (Carlsbad, CA, USA): PARP2
(39744, rabbit). From Sigma Aldrich (St. Louis, MO,
USA): tubulin (T6199, mouse). From Cell Signaling
(Danvers, MA, USA): fibrillarin (C13C3). From Merck-
Millipore (Billerica, MA, USA): phosphor-Histone
H2A.X (Ser139). From Jackson ImmunoResearch
Laboratories (Suffolk, UK): secondary FITC-conjugated
AffiniPure goat anti-mouse, secondary Cy3TM -
conjugated AffiniPure goat anti-mouse. From Invitrogen
(Gibco, Invitrogen, CA, USA): Alexa-Fluor 488 anti-
rabbit IgG (A11008). The antibody 10H anti-PAR was
used to identify PAR by immunofluorescence (IF).
RNA analysis
RNA was purified using TRIzol! RNA Isolation Reagent
(500 ml, Life Technologies, CA, USA) and reverse
transcribed according to the supplier’s protocol (High
Capacity cDNA Reverse Transcription Kit, Applied
Biosystems, Foster City, CA, USA). Quantitative real-
time polymerase chain reactions (qPCR) were performed
with SYBR! green SensiMix SYBR Hi-ROX Kit (Bioline
Reagents Ltd., London, UK) and a Rotor-Gene Q 2plex
HRM System (Qiagen, Hilden, Germany).
2 Nucleic Acids Research, 2014
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Cell lysis, sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and western blot analysis
Whole cell lysis was performed either with trypsinized cells
or directly on plates by using RIPA lysis buffer (50mM
Tris, pH 8, 400mM NaCl, 0.5% NP40, 1% DOC, 0.1%
SDS, 1 mg/ml pepstatin, 1 mg/ml bestatin, 1 mg/ml
leupeptin, 2mM PMSF, 10mM b-Glycerophosphate,
1mM NaF and 1mM dithiothreitol; 10min, 4!C).
Proteins were quantified using the Lowry assay and, if
not otherwise indicated, 30 mg of protein extract was
loaded and separated on a 10 or 12% SDS-polyacrylamide
gel (120V, 2 h). The gel was blotted on a polyvinylidene
difluoride membrane and analysed by using protein
specific antibodies.
Immunofluorescence microscopy
Cells were seeded on coverslips (105 cells per well in a
24-well-plate) and grown overnight. After H2O2 (1mM
in FCS-free medium, 10min), MNNG (500mM in FCS-
free medium, 30min) or medium-only treatment, cells
were fixed (methanol: acetic acid 3:1, 5min on ice),
washed twice with phosphate buffered saline (PBS) and
incubated with antibody (1:350) in PBS (containing 5%
milk and 0.05% Tween, 1 h at room temperature or over-
night at 4!C). When indicated, 4% PFA was used as
fixation method (15min, room temperature). Cells were
then incubated with antibody for 1 h at room temperature.
After washing with PBS, coverslips were mounted with
Vectashield containing 40,6-diamidino-2-phenylindole
(DAPI; Vector Laboratories, Burlingame, CA, USA).
Conventional microscopy was carried out using a Leica
DMI 6000B light microscope (Leica microsystems GmbH,
Wetzlar, Germany). Confocal laser scanning microscopy
was carried out with a Leica SP 5 resonant APD system
(Leica microsystems GmbH, Wetzlar, Germany).
The mean PAR signal intensity per cell was quantified
with ImageJ (37) in at least 100 cells per replicate. The
color threshold was set for Max entropy and B&W.
According to the intensity of the picture, the threshold
was set for each experiment the same way; thus, different
replicates were comparable with each other.
Co-localization was quantified with Imaris (Bitplane,
Belfast, UK) using the co-loc application. The thresholds
were set for all three channels (DAPI, blue; PAR, red; and
fibrillarin, green) and kept for the whole analysis. At least
50 cells were analyzed for H2O2 treated samples (from
three biological replicates) and at least 25 cells were
analyzed for H2O2 ActD treated samples (from two bio-
logical replicates).
In vitro RNA transcription
Linearized vectors containing rRNA sequences (mouse
rRNA from "16 to +130 and "232 to "1) and control
sequences (36) were used to in vitro transcribe RNA using
T7 polymerase. After DNase I treatment, transcripts were
double purified using TRIzol reagent (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s
protocol.
In vitro ARDT1 or ARTD2 activity assay
Ten picomoles of baculovirus-purified MYC-
hARTD1(wt)-HIS or purified human ARTD2(fl)-HIS
was incubated with NAD+ in the reaction buffer
(250mM Tris–HCl, pH 8, 20mM MgCl2, 1.25mM
dithiothreitol, 5 mg/ml P/B/L–proteinase inhibitors, 30!C,
10min). Five picomoles of EcoRI linker DNA or different
concentrations as indicated of short RNA transcripts were
added to the reaction. For ADP-ribosylation reactions,
radioactive NAD+ (32P, final concentration 100 nM) and
nonradioactive NAD+ (final concentration 1.6 or 16 mM)
were added. Reactions were terminated by adding
Laemmli buffer and subsequent boiling of the samples
(5min, 95!C). SDS-PAGE was performed; gels were
stained with coomassie, destained and subjected to film
exposure. The autoradiography was quantified with the
software GelEval (http://www.frogdance.dundee.ac.uk/).
In vitro poly-ADP-ribose-glycohydrolase (PARG) assay
ARTD1 auto-ADP-ribosylation was carried out as
described before and the reaction mix was purified over
illustra MicroSpin G-50 Columns (GE Healthcare GmbH
Europe, Freiburg, Germany). Equal amounts of reaction
mix were added to prechilled tubes containing baculo-
purified hPARG-(fl) (2 pmol). Reactions were carried
out in the presence or absence of the indicated molecules.
Nothern blot and Northwestern analysis
Purified RNA from NIH/3T3 or T24 cells pretreated with
ActD (50 ng/ml for 0.5 h, 4 h or 20 h) and rRNA tran-
scripts were monitored by hybridization to a 32P-labeled
riboprobe complementary to +1/+130 mouse or human
rRNA sequences. Northwestern analysis was performed
as described previously (36).
RESULTS
H2O2 treatment predominantly induces nucleolar PAR
formation
To investigate the localization and molecular mechanism
of PAR formation, T24 cells were treated with H2O2
(1mM for 10min). PAR formation was analysed by IF
using a 10H anti-PAR antibody and both conventional
and confocal fluorescence microscopy. The PAR signal
was localized mainly to regions of the nucleus that were
stained weakly with DAPI, indicating that nucleoli are
sites of PAR formation (Figure 1A). The PAR signal in
T24 cells treated with H2O2 co-localized with ARTD1,
which suggests that ARTD1 is at least partly responsible
for PAR synthesis in response to oxidative stress in T24
cells (Figure 1B). Co-staining with anti-Pol I and anti-
fibrillarin antibodies suggested partial co-localization
with the PAR signal (Figure 1C and D). Computerized
analysis of the acquired images revealed that 60–65% of
the fibrillarin co-localized with a strong PAR signal
(Figure 1E). Similar levels of co-localization of fibrillarin
with PAR signals were observed in H2O2-treated NIH/
3T3 (Figure 1D and E). H2O2-treated HeLa cells and
MEFs displayed a similar location of the PAR signal in
Nucleic Acids Research, 2014 3
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Figure 1. H2O2 treatment induces nucleolar poly-ADP-ribose formation. Confocal immunofluorescence microscopy of PAR (red) was performed
after H2O2 treatment (1mM, 10min). (A) Z-Stack-resolution of T24 cells, bar=10 mM. (B) Double-staining of T24 cells: PAR (red), ARTD1
(green), bar=10mM. (C) Double-staining of T24 cells: PAR (red), RNA Pol 1 (green), bar=10mM. (D) Double staining of T24 (upper row) and
3T3 (lower row) cells after H2O2 treatment (1mM, 10min): PAR (red) and fibrillarin (green), bar=10 mM. (E) Quantification of the co-localization
of the PAR signal and fibrillarin staining in T24 and NIH/3T3 cells. (F) Confocal IF microscopy of PAR (red) after H2O2 treatment (1mM, 10min)
was analyzed in MEF and HeLa cells. Bar=10 mM.
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nucleoli (Figure 1F). Taken together, these results indicate
that the nucleoli are the main location of cellular PAR
formation during oxidative stress.
ActD treatment enhances nucleolar PAR formation on
H2O2 and MNNG stimulation
Although H2O2- and MNNG-induced PAR formation has
been attributed to DNA damage, a link between stress-
induced PAR synthesis and Pol I-dependent transcription
has not been documented previously. To investigate this
possibility, we pretreated cells for 20 h with a low dose of
ActD (50 ng/ml), which inhibits Pol I-dependent transcrip-
tion (38), before the exposure to H2O2 or MNNG.
Intriguingly, pretreatment with ActD followed by
exposure to H2O2 or MNNG increased both the number
of PAR-positive T24 cells and the intensity of the PAR
signal in comparison with cells not pretreated with ActD
(Figure 2A and B). A similar effect of ActD on the PAR
signal was also observed in cells fixed with PFA, thus
excluding the possibility that the results obtained by the
methanol/acetic acid fixation protocol were an artifact
(Supplementary Figure S1A, upper part).
In PFA-fixed cells, PAR formation assessed by confocal
microscopy was also localized to DAPI-poor regions
(Supplementary Figure S1A, lower part). However, the
apparent extent of PAR and fibrillarin co-localization in
PFA-fixed cells was less than that in methanol/acetic acid-
fixed cells. This discrepancy could be due to PFA fixation
leading to masking of the epitope for antibody recogni-
tion, an observation that we also made for other nucleolar
proteins, which can only be detected in nucleoli when the
denaturating action of methanol fixation is used (R.S.,
unpublished observation). ActD enhanced H2O2- or
MNNG-induced PAR formation also in NIH/3T3,
HeLa and MDA-MB-231 cells (Supplementary Figure
S1B–D), indicating that the observed ActD effect is bio-
logically conserved. ActD on its own did not induce PAR
formation, indicating that ActD caused increased PAR
formation by enhancing the signals induced by H2O2 or
MMNG. Furthermore, ActD did not alter localization of
PAR to nucleoli, as indicated by the unchanged co-
staining with fibrillarin (Figure 2C and Supplementary
Figure S1D).
To analyze whether ActD-induced PAR formation was
due to the induction of cell death, cell viability was moni-
tored. ActD pretreatment with the low concentration of
50ng/ml did not significantly affect cell viability, while
higher ActD concentrations (1mg/ml) strongly reduced
cell viability in T24 cells (Figure 2D). To exclude DNA
damage as the stimulus for PAR formation, the levels of
histone H2AX phosphorylation (gH2AX), a modification
that occurs at sites flanking DNA double-strand breaks
(DSBs) (39), were analyzed. Both of the positive controls,
the topoisomerase II inhibitor etoposide (50mM, 16h), as
well as high doses of ActD, induced gH2AX formation in
T24 cells (Figure 2E). We thus conclude that the strong
PAR signal induced by the pretreatment of T24 cells with
the low concentration of ActD (50 ng/ml) was not due to
DNA damage or cell death. As PAR formation has previ-
ously been reported to occur under replicative stress (40),
we also analyzed the PAR signal as well as the gH2AX
formation in quiescent (G0 phase) T24 cells, on combined
ActD and H2O2, or ActD, etoposide and MNNG treat-
ment (Figure 2E and Supplementary Figure S2A).
Comparable with nonarrested cells, quiescent cells treated
with the low ActD concentration also displayed PAR for-
mation, but did not show induction of gH2AX, indicating
that enhanced PAR formation on ActD treatment does not
depend on replicative stress and cell proliferation.
We next tested whether enhanced PAR formation
depends on Pol I transcription. The analysis of 45S pre-
rRNA levels confirmed that ActD was effective in
impairing pre-rRNA synthesis (>90%), while H2O2 or
MNNG reduced pre-rRNA levels only by 25–40%
under the tested conditions (Supplementary Figure S2B).
In contrast to ActD, pretreatment with the RNA Pol II
inhibitor a-amanitin did not induce PAR formation
(Supplementary Figure S2C), indicating that formation
of ActD-mediated PAR formation depends on RNA Pol
I transcription. Because PAR formation was inhibited by
Olaparib, an inhibitor of ARTDs including ARTD1 and
ARTD2 [Supplementary Figure S2D, (41)], ARTD1 and/
or ARTD2 could potentially be involved in the synergistic
effect between stress signaling and the interference of 45S
pre-rRNA synthesis for PAR accumulation in the
nucleolus.
ARTD2, but not ARTD1, is responsible for the
ActD-dependent enhancement of PAR formation
after H2O2 or MNNG treatment
To investigate whether ActD exerts its synergistic effect
through ARTD1 and/or ARTD2, T24 cells were
depleted of either ARTD1 or ARTD2 by siRNA
(Supplementary Figure S2E), pretreated with ActD as
indicated and PAR formation was induced by H2O2 or
MNNG. PAR formation was quantified by evaluating
the mean signal intensity of immunostained cells. PAR
levels were more strongly induced after H2O2 treatment
as compared with MNNG treatment (Figure 3A and B).
ActD pretreatment for 4 or 20 h enhanced the mean PAR
intensity per cell irrespective of whether H2O2 or MNNG
was used, while short pretreatment of only 30min had no
effect. This enhancement of PAR formation on ActD
treatment was more prominent in MNNG-treated cells
as compared with H2O2-treated cells under the tested con-
ditions (Figure 3B). Knockdown of ARTD1 almost com-
pletely abolished PAR formation in T24 cells treated with
H2O2, indicating that ARTD1 is responsible for most of
the H2O2-induced PAR formation (Figure 3C). However,
prolonged (4–20 h, 50 ng/ml) pretreatment of
ARTD1-silenced cells with ActD strongly enhanced
H2O2-induced PAR formation, despite the strong sus-
tained reduction of ARTD1 protein levels (Figure 3C).
These results indicate that the synergistic effect between
oxidative stress and the inhibition of 45S pre-rRNA
synthesis on PAR accumulation in the nucleolus is not
mediated by ARTD1. In contrast, compared with
siMOCK-treated cells, no additional increase in PAR
formation was observed after 4–20 h of ActD pretreat-
ment in ARTD2-depleted T24 cells (Figure 3C), indicating
Nucleic Acids Research, 2014 5
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Figure 2. ActD treatment increases nuclear poly-ADP-ribose formation on H2O2 and MNNG stimulation. (A) Immunofluorescence microscopy of
T24 cells was examined after H2O2 (1mM, 10min) and/or ActD treatment (50 ng/ml, 20 h) and stained for PAR formation (red).
(B) Immunofluorescence microscopy of T24 cells after MNNG (500 mM, 30min) and/or ActD treatment (50 ng/ml, 20 h) was examined.
(C) Quantification of the co-localization of the PAR signal and fibrillarin staining in T24 and NIH/3T3 cells pretreated with ActD. (D) Viability
assay (Alamar blue assay) of T24 cells treated with ActD (50 and 1000 ng/ml) for 4 h or 20 h [n=3, one-way analysis of variance (ANOVA),
followed by Tukey’s post hoc test]. (E) Immunofluorescence microscopy of T24 cells stained for g-H2AX after ActD treatment (50 and 1000 ng/ml
for 20 h) and etoposide (50 mM for 16 h), either in cycling or in quiescent T24 cells.
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that the stimulatory ActD effect on H2O2-induced PAR
formation was mainly regulated by ARTD2. The presence
of ARTD2, but not of ARTD1, also seemed to be respon-
sible for the increased PAR formation observed after co-
treatment of ActD and MNNG in T24 cells after 4 h
(Figure 3D). The slight, but not significant, increase of
the PAR signal in cells pretreated with ActD for 20 h
and co-treated with MNNG may hint at the delayed and
attenuated stimulation of ARTD1, or an additional
ARTD family member that catalyzes additional PAR
formation under these conditions. H2O2 or MNNG
treatment in combination with ActD in NIH/3T3 cells
and subsequent quantification of the PAR formation by
IF or visualization by western blot further confirmed that
ARTD2 is responsible for the stimulatory ActD effect also
in mouse cells (Supplementary Figure S3A–H for H2O2 or
Supplementary Figure S4A and B for MNNG). Together,
these results indicate that ARTD2 is involved in PAR for-
mation in response to H2O2- or MNNG-treatment in
combination with ActD in T24 and NIH/3T3 cells.
ARTD2 activity is stimulated by rRNA in vitro
The described synergistic effect between ActD and H2O2/
MNNG on PAR formation could either be due to an in-
hibition of PAR degradation or a stimulation of PAR
synthesis. The former was studied by determining
whether ActD affects activity of the PARG, the primary
enzyme responsible for degrading protein-bound poly-
ADP-ribose (Figure 4A). In vitro 32P-labeled PARylated
ARTD1 was incubated with PARG in the presence of
ActD or rRNA, and PARylated ARTD1 levels were
monitored by autoradiography. Treatment with ActD or
rRNA did not prevent degradation of PAR moieties of
ARTD1, indicating that neither ActD nor rRNA affects
PARG activity.
The results described above indicate that H2O2 induces
PAR formation in the nucleoli (Figure 1). ActD impairs
45S pre-rRNA synthesis by preventing Pol I elongation
through the rDNA coding region and leads to an accumu-
lation of short RNA transcripts corresponding to se-
quences immediately downstream of the transcription
start site (+1/+130), as detected by northern blotting
(Figure 4B and Supplementary Figure S5A) (30,31). We
described above that only prolonged treatment with ActD
(4 and 20 h) enhanced formation of PAR in cells treated
with H2O2 or MNNG (Figure 3). Because PAR formation
correlated with the inhibition of 45S pre-rRNA synthesis
(Supplementary Figure S5B), we hypothesized that the
production of short rRNA transcripts induced by ActD
treatment might stimulate ARTD2 activity. To test this
hypothesis, we investigated the in vitro ARTD2
automodification in the presence of in vitro synthesized
rRNA transcripts (corresponding to rDNA sequences
from !16 to +130 bp) using P32-labeled NAD+ to
monitor ADP-ribosylation (Figure 4C). Densitrometric
analysis of the incorporated radiolabeled ADP-ribose
revealed that the automodification of ARTD2 was
stimulated by rRNA 3.4-fold stronger in comparison
with double-stranded DNA, while rRNA stimulated
ARTD1 only 0.7-fold compared with the stimulation
with double-stranded DNA (Figure 4C). This effect did
not seem to be mediated by specific rRNA sequences, as
other nonnucleolar RNA transcripts were able to stimu-
late ARTD2 activity to a similar extent (Supplementary
Figure S5C). In contrast to ARTD2, ARTD1 was strongly
activated by double-stranded DNA and, as previously
described (36), only exhibited 60% of its activity in the
presence of RNA as compared with DNA (Figure 4C).
Because the ActD effect was only observed in the
presence of genotoxic stress, we tested whether the activa-
tion of ARTD2 by RNA depends on double-stranded
DNA. Addition of DNA did not enhance the stimulatory
Figure 3. ARTD2 is responsible for the ActD-dependent increase in
poly-ADP-ribose formation. Quantitative PAR analysis of siMock-,
siARTD1- and siARTD2-treated T24 cells was performed after treat-
ment with ActD (50 ng/ml for 0.5, 4 and 20 h) and H2O2 (1mM,
10min) or MNNG treatment (500mM, 30min). At least 100 cells
were analyzed per replicate (for 0.5 h; n=2 for siARDT1 and
siARTD2 samples, for other conditions n=3–5, one-way ANOVA
with Tukey’s post hoc test was performed). (A) siMock T24 cells
were treated with H2O2. (B) siMock T24 cells were treated with
MNNG. (C) H2O2 treated siARTD1 (left) and siARTD2 (right) T24
cells. (D) MNNG-treated siARTD1 (left) and siARTD2 (right) T24
cells. n.s.: P> 0.05; *P" 0.05; **P" 0.01; ***P" 0.001.
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Figure 4. ARTD2 activity is stimulated by rRNA in vitro and binds to RNA via the SAP domain (A) In vitro radioactive PARG assay carried out
with in vitro modified ARTD1. PARG was added to each reaction in combination with pretreatment of ActD (50 ng/ml) or rRNA (146 nt). The
PARG reaction was performed for 15min at 4 !C. Upper panel shows the autoradiography (32P) and the lower panel the corresponding coomassie
blue–stained gel (CB) of a representative experiment. Densitometric analysis of the radioactive signals was performed as described in M&M, and
values obtained are indicated at the bottom of the panel. The PARG untreated value was arbitrarily set to 1. (B) Northern blot analysis of NIH/3T3
cells treated with ActD (50 ng/ml for 0.5, 4 and 20 h). Hybridization was performed with a riboprobe corresponding to +1/+130 mouse rRNA
sequences. The lower panel shows 28S and 18S rRNA stained with ethidium bromide. (C) In vitro radioactive ARTD2 and ARTD1 activity assay
was performed with 100 ng NAD+ (32P) in the presence of in vitro transcribed rRNA piece (146 nt), DNA linker or ActD (50 ng/ml). CB =
coomassie blot. Densitometric analysis of the radioactive signals was performed as described in M&M and values obtained are included in the
result section. (D) In vitro radioactive ARTD2 activity assay was performed with 1.6 mM NAD+ (32P) and in vitro transcribed rRNA fragment
(146 nt) of different amounts (0.5, 5 and 10 pmol) and in presence or absence of 0.5 pmol DNA linker. Reaction was carried out at 30 !C, 10min.
Densitometric analysis of the radioactive signals was performed as in panel A and values obtained are indicated at the bottom of the panel. The
untreated sample was arbitrarily set to 1. (E) In vitro radioactive ARTD2 activity assay with ARTD2 mutants was performed with 1.6 mM NAD+
(32P) in presence or absence of 5 pmol rRNA fragment (146 nt). FL/wt= full-length human ARTD2, ARDT2 !SAP mutant 95–583 aa, ARTD2
!S!W mutant 231–583 aa, ARTD2 !WGR mutant without WGR domain (deleted aa 116–193). Densitometric analysis of the radioactive signals
was performed as in panel (A) and values indicated at the bottom of the panel. The untreated wild-type sample was arbitrary set 1. (F) ARTD2 binds
to RNA via the SAP domain. Northwestern analysis. Membrane-bound recombinant wild type and the indicated ARTD2 mutants as well as ARTD1
(see coomassie-stained gel, CB) were incubated with radiolabeled rRNA ("16 to+130) and bound RNA was visualized by autoradiography (32P).
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effect of RNA on ARTD2, confirming that RNA stimu-
lates ARTD2 independent of DNA (Figure 4D).
ARTD2 binds to RNA through its SAP domain
To define which domain of ARTD2 is responsible for the
RNA-mediated activation, we compared the effect of
RNA on the activities of human ARTD2FL (full length)
and ARTD2!SAP (aa 95–583), a mutant that lacks the
SAP domain and displays similar basal activity as
ARTD2FL. Although ARTD2FL was stimulated by
RNA, the deletion of the SAP domain impaired RNA-
mediated activation (Figure 4E). In addition to the loss
of the stimulation by RNA, the additional deletion of the
WGR domain (aa 231–583, ARTD2 !S!W), or removal of
the WGR domain alone (deletion of aa 116–193, ARTD2
!WGR) resulted in a strong reduction of the general
ARTD2 activity (Figure 4E). RNA-binding experiments
with these proteins confirmed that the SAP domain is re-
sponsible for the binding of ARTD2 to RNA. Together,
these results suggest that RNA is a potent activator of
ARTD2 enzymatic activity predominantly through the
SAP domain, and that the WGR domain is an important
structural element for the overall activity of the enzyme.
DISCUSSION
ADP-ribosylation has been implicated in several nucleolar
processes such as ribosome biogenesis, formation of
rDNA heterochromatin and stress sensing (32,34,36,42–
44). Here, we show that H2O2 or MNNG induces PAR
formation in the nucleoli of both mouse and human cells.
This is in agreement with previous studies that found
ARTD1 and ARTD2 to localize to nucleoli (34). The com-
bination of H2O2 or MNNG treatment with low doses of
ActD revealed a synergistic effect on PAR formation that
is mediated by ARTD2. It was well-known before that
ActD treatment leads to the accumulation of short
rRNA transcripts, which might be responsible for the en-
hancement of PAR formation. Short rRNA transcripts
were able to strongly stimulate ARTD2 activity via the
SAP/WGR domain, while double-stranded DNA did not
exhibit this effect. Our findings thus reveal a new activator
for ARTD2-dependent ADP-ribosylation, which has
important implications for the future analysis of the bio-
logical role of ARTD2 in the nucleus.
ADP-ribosylation and in particular the homologous
enzymes ARTD1 and ARTD2 have been traditionally
implicated in the response to DNA damage. An important
cornerstone for this model is the strong in vitro activation
of ARTD1 by double-stranded or nicked DNA, as well as
the detection of PAR on treatment of cells with genotoxic
compounds. In these DNA damage-dependent processes,
ARTD2 displays much less activity than ARTD1, raising
the question whether molecules other than activators of
ARTD1 activate ARTD2. Our results strongly suggest
that instead of binding to sites of DNA damage,
ARTD2 associates with RNA in the nucleolus, providing
an alternative cue to identify and respond to DNA
damage. In support of this, recent data have implicated
site-specific Dicer and Drosha RNA moieties in the
control of DNA damage (45). Furthermore, the activation
of ARTD2 by RNA may also be part of an intricate
network of RNA surveillance and repair mechanisms to
preserve RNA quality (46–48). The identification of
ARTD2 activation by RNA is a new and unexpected
result that may indicate an additional mean for monitor-
ing not only genome integrity, but also other processes
specific for ARTD2. Genetic disruption of ARTD2, but
not of ARTD1, affects various differentiation processes in
mice, including spermatogenesis (49), adipogenesis (50)
and the survival of thymocytes (51).
Interestingly, the stimulation of ARTD2 in vivo was
dependent on the co-stimulation with ActD and H2O2 or
MNNG, indicating that additional signals induced by
H2O2 or MNNG are required for the activation of
ARTD2 by RNA. These signals might include the
damage of RNA, as oxidative damage in RNA is
usually higher than in DNA (52). However, our experi-
ments with H2O2-pretreated RNA did not strengthen this
hypothesis (data not shown). Alternatively, the treatment
of cells with H2O2 or MNNG might induce signaling
cascades that lead to the posttranslational modification
of ARTD2, which is required for the stimulation with
RNA, besides damaging the DNA. Future studies of the
nucleolar ADP-ribose acceptors and the effect of ADP-
ribosylation on the response to RNA damage are needed
to reveal and define these functions in detail. Interestingly,
the ActD effect was observed in both human and mouse
cells, suggesting that the stimulation of ARTD2 is a bio-
logically conserved effect.
Under the study conditions described here, cellular
PAR formation on H2O2/MNNG treatment occurred to
a large portion within nucleoli. Growing evidence indi-
cates that the nucleolus plays a key role in monitoring
and responding to cellular stress. After exposure to
extra- or intracellular stress, signal pathways induce
rapid downregulation of 45S pre-rRNA synthesis that is
followed by perturbation of nucleolar structure, cell cycle
arrest and stabilization of p53 (53). The formation of high
levels of PAR in nucleoli under genotoxic stress conditions
might be part of this nucleolus-dependent signaling.
Whether PAR formation is due to a high accessibility of
nucleolar DNA and RNA to chemical agents and how this
occurs remains to be investigated.
Previous studies have shown that RNA is a key regula-
tor of ARTD1 in the nucleolus [(36) and Figure 4D/F].
Nucleolar localization of ARTD1 is dependent on RNA
and ARTD1 binds in vivo and in vitro to the nucleolar
noncoding pRNA, an intergenic transcript implicated in
the establishment of rDNA heterochromatin (54). pRNA
associates with the zinc finger DNA binding domain of
ARTD1 and stimulates ARTD1 activity, although to a
lesser degree than double-stranded DNA [(36) and
Figure 4D].
In this work, we provide evidence that RNA is a key
regulator of ARTD2 enzymatic activity. The nucleolar
localization of overexpressed ARTD2 has already been
described (34) and the currently available antibodies do
not permit a direct immunofluorescent localization of
endogenous ARTD2 or determination of how RNA
affects nucleolar occupancy of ARTD2. However, we
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could demonstrate that RNA strongly activates ARTD2
activity. In contrast to ARTD1, double-stranded DNA
did not activate ARTD2. These findings suggest that the
structure and nature of nucleic acid is an important deter-
minant for the regulation of ARTD2 function. Consistent
with this, recent analyses with several DNA structures
mimicking intermediates of different DNA metabolizing
processes revealed that ARTD2 activation efficiency did
not correlate with K(d) values for DNA (55). ARTD2
displayed the highest affinity for flap-containing DNA,
but was more efficiently activated by 50-overhang DNA,
suggesting that single-stranded nucleic acids might be a
general stimulator of ARTD2. The stimulation did not
seem to be sequence-specific, as other RNAs tested were
also able to strongly stimulate ARTD2 (36). We have
identified SAP to be the main domain responsible for
the stimulation by RNA. The SAP motif (after SAF-A/
B, Acinus and PIAS) is a putative DNA/RNA binding
domain found in diverse nuclear and cytoplasmic
proteins (56,57). Based on the presented findings, it is
thus possible that other proteins with a SAP motif simi-
larly may bind RNA and be regulated by this binding.
Interestingly, deleting the WGR domain only abolished
the stimulation by RNA, but also the overall activity of
ARTD2, indicating that the structural arrangement of the
SAP and the CAT motif is functionally relevant.
Together, the strong activation of ARTD2 by RNA
through the SAP domain is a likely underlying cause for
the distinct and complementary functions mediated by this
homolog as compared with ARTD1. The fact that RNA
stimulates PAR formation by ARTD2 has not only mech-
anistic implications but also sheds new light on how
ARTD2 and poly-ADP-ribosylation function during the
genotoxic stress response.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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4 Discussion 
The epigenetic state of the nucleolus regulates chromatin 
plasticity and pluripotency of embryonic stem cells 
The aim of this work was to elucidate the mechanisms that control formation of 
nucleolar heterochromatin during stem cell differentiation. Furthermore, we 
investigated whether the nucleolus is implicated in the open chromatin and 
pluripotent state of ESCs and its contribution in establishing heterochromatic 
structures during differentiation. The data of this work unravelled that nucleolar 
rRNA genes acquire heterochromatic structures upon ESC differentiation, timely 
coinciding with the maturation of heterochromatin at centric and pericentric 
repeats. This work led to the discovery that lack of nucleolar heterochromatin in 
ESCs is caused by the impairment of intergenic-spacer (IGS)-rRNA processing 
that abolishes the nucleolar repressor TIP5 association with TTF1 and its docking 
to rDNA. Moreover, we showed the epigenetic state of the nucleolus to be a key 
regulator of ESC nuclear architecture and chromatin plasticity that serves to 
control pluripotency and commitment.      
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4.1 RNA processing modulates distinct functions of the same 
ncRNA  
lncRNAs have been implicated in a variety of epigenetic regulatory processes 
leading to the establishment of chromatin conformation patterns that ultimately 
result in the fine control of genes (Costa, 2008). Understanding how lncRNAs are 
regulated is an important challenge aimed to build complex regulatory scripts out 
of lncRNAs.  
lncRNA encompasses different classes of RNA transcripts, including enhancer 
RNAs, small nucleolar RNA (snoRNA) hosts, intergenic transcripts, and 
transcripts overlapping other transcripts in either sense or antisense orientation. 
The widespread use of these transcripts by eukaryotic cells led to propose that 
they would be the main molecular advance in higher organisms to coordinate 
complex molecular network (Mattick, 2007).  
A common emerging theme of lncRNAs is that they form ribonucleic acid-protein 
interactions, acting as scaffold to join several proteins together in a complex. An 
example of this is the lncRNA HOTAIR, which can simultaneously bind both the 
PRC2 (Polycomb Repressive Complex 2 that promotes H3K27me3) and the 
LSD1-CoREST complex  (Lysine specific demethylase 1-Corepressor to REST 
that demethylates H3K4me2) via specific domains of the RNA structure (Tsai et 
al., 2010). This combination of interactions coordinates H3K27 methylation and 
H3K4me2 demethylation, ensuring gene silencing. The scaffold action is also 
supported by recent results showing that approximately a third of lncRNAs 
associate with chromatin-modifying complexes (Khalil et al., 2009).  
In this work, we showed a novel way in which lncRNA might act in the regulation 
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of epigenetic states. We showed that the regulation of IGS-rRNA processing is a 
key determinant for the control of the epigenetic state at rDNA and propose that 
processing represents a mean of lncRNA regulation to modulate distinct functions 
of the same lncRNA. We determined that IGS-rRNA processing is a regulated 
process and that impairment of IGS-rRNA processing in ESCs prevents 
recruitment of TIP5 to rDNA and formation of rDNA heterochromatin. Although the 
mechanisms that prevent IGS-rRNA processing in ESCs are yet to be determined, 
our results demonstrated that the lack of mature pRNA impairs formation of rDNA 
heterochromatin in ESCs. Indeed, addition of pRNA in ESCs is sufficient to recruit 
TIP5 to rDNA and to establish rDNA repressive structures. The results showed 
that while IGS-rRNA abolishes the association of TIP5 with TTF1, pRNA promotes 
this association that serves to dock the complex at rDNA and to establish 
nucleolar heterochromatin. Thus, the same ncRNA can prevent or promote 
protein complex assembly and its processing controls the switch to these 
functions. Based on these results, it would not be surprising if processing 
emerges as a more general mechanism of lncRNA regulation. 
 
The potential of RNA to bind to complementary DNA sequences has led many to 
hypothesize that lncRNAs may serve as molecular guides to target chromatin-
modifying enzymes without the need of adaptor proteins. An example of this is 
pRNA. Although pRNA sequences greatly deviate from the common purin motif 
required for Hoogsteen configurations (Buske et al., 2011), they were recently 
highlighted as an example of RNA-DNA recognition rules because of their ability 
to recruit DNMT3b through triple helix formation with rDNA (Schmitz et al., 2010). 
The requirement of pRNA to retain TIP5 at rDNA and within nucleoli has led to the 
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hypothesis that pRNA guides TIP5 to rDNA (Mayer et al., 2008; Mayer et al., 
2006) and that triple-helix might mediate this process (Bierhoff et al., 2013). 
However, a mechanism of TIP5 targeting through DNA-protein recognition rules 
was previously suggested based on the association of TIP5 with TTF1 and its 
dependency on rDNA binding (Nemeth et al., 2004; Santoro and Grummt, 2005; 
Strohner et al., 2001). Our results joined the two proposed models in one same 
pathway by showing that pRNA guides TIP5 to rDNA in trans and that TIP5-TTF1 
association is mediated by pRNA and impaired by IGS-rRNA. The data strongly 
support a model where pRNA mediates TIP5 targeting to rDNA through DNA-
protein recognition rules and that the establishment of rDNA heterochromatin in 
ESCs does not depend on triple-helix formation. Indeed, pRNA hairpin loop region 
was sufficient for TIP5 recruitment to rDNA, the association with TTF1 and the 
formation of rDNA heterochromatin. Whether triple-helix pRNA is implicated in 
other physiological processes it remains an issue to be further investigated.  
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Figure 6. Model showing the formation of rDNA heterochromatin in ESC differentiation and 
its influence in nuclear heterochromatin. IGS-rRNA is not processed in ESCs with consequent 
lack of mature pRNA. The unprocessed transcript impairs the association of TIP5 with TTF1, 
inhibiting recruitment to rDNA and formation of heterochromatin. Upon differentiation, IGS-rRNA is 
processed and generates pRNA that allows TIP5 to interact with TTF1 and to be recruited to 
rDNA. The arrow depicts the influence of rDNA heterochromatin in the formation of nuclear 
repressive chromatin structures. 
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4.2 The epigenetic state of nucleolar chromatin regulates nuclear 
architecture and pluripotency of ESCs 
The spatiotemporal organization of genomes in the nucleus is an emerging key 
player to regulate genome function. For instance, the remodelling of the open and 
transcriptional permissive chromatin of ESCs toward a highly condensed 
heterochromatic form characterizes the exit from pluripotency and the progression 
into differentiated states. We determined here that the nucleolus is not only the 
place where ribosomes are produced but it also plays a role in nuclear 
architecture and pluripotency by regulating heterochromatic structures elsewhere 
in the genome. The formation of heterochromatin within nucleoli, at rRNA genes, 
represents an important step for the establishment of repressive chromatin 
structures at regions of the genome located outside of the nucleolus.  
We determined that rRNA genes acquire heterochromatic structures upon ESC 
differentiation, timely coinciding with the maturation of heterochromatin at centric 
and pericentric repeats. We showed that these two classes of heterochromatic 
sequences are tightly linked. Indeed, specific targeting of heterochromatin at 
rRNA genes in ESCs through pRNA promotes the maturation of centric and 
pericentric heterochromatin and a global increase in H3K9me2 amounts to levels 
similar to those found in differentiated cells. The crosstalk between rDNA and 
nuclear repetitive sequences is also in line with recent data from our and other 
labs showing loss of heterochromatin at both rDNA and major and minor satellites 
of somatic cells depleted of TIP5 (Guetg et al., 2010; Postepska-Igielska et al., 
2013). Establishment of repressive structures at non-nucleolar regions by rDNA 
heterochromatin might occur either through spreading mechanisms (i.e. from 
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silent rRNA repeats to adjacent centric-pericentric repeats) and/or formation of a 
nucleolar/perinucleolar compartment enriched in chromatin repressor complexes, 
which becomes attractive for genomic regions that have to be repressed. An 
important example is provided by the perinucleolar targeting of the inactive X that 
was implicated for the maintenance of its repressed epigenetic state (Zhang et al., 
2007). In line with this, recent high-resolution sequencing of the nucleolus 
unraveled the presence of regions with low gene density and significantly 
enriched in transcriptional repressed genes (Nemeth et al., 2010; van 
Koningsbruggen et al., 2010). Therefore, anchoring of heterochromatin at the 
nucleolus might serve similar functions like the ones described for the nuclear 
periphery that is responsible for the integrity of mammalian heterochromatin 
(Pinheiro et al., 2012; Towbin et al., 2012). Consistent with this, genomic regions 
localized at the lamina (LADs) after cell division were shown to relocate either at 
the lamina or at the nucleolus (Kind et al., 2013), suggesting interchangeable 
roles in regulating and maintaining heterochromatic states.    
 
The results described here suggested that the task of rRNA genes is not only to 
synthesize rRNA. Indeed, accumulating evidences indicated that formation of 
silent rDNA heterochromatin is not implicated in rRNA transcription regulation. 
Silent rRNA repeats, present in all somatic cells, maintain their chromatin and 
epigenetic state independently of transcriptional activity and are stably propagated 
throughout the cell cycle (Conconi et al., 1989), a result in agreement with the 
many data showing that rRNA synthesis is regulated by modulating the activity of 
transcriptionally competent (active) genes and not by changing the number of 
silent genes (reviewed in (Santoro, 2012)). Our results indicated that the 
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epigenetic state of rRNA genes contributes to nuclear architecture and cellular 
functions such as pluripotency and ESC differentiation by controlling the balance 
between heterochromatin and euchromatin. The relationship between nucleolar 
and nuclear chromatin is also supported by data showing that the maintenance of 
rDNA heterochromatin is required for genome stability. In the yeast S. cerevisiae, 
Drosophila and mouse cells disruption of rDNA heterochromatin instigates 
genome instability at the rDNA and satellite repeat arrays (Guetg et al., 2010; 
Mekhail et al., 2008; Peng and Karpen, 2007). In addition, rDNA deletions in 
Drosophila result in reduced heterochromatin-induced gene silencing elsewhere in 
the genome and the extent of the rDNA deletion correlates with the loss of 
silencing in much the same manner as mutations in known protein 
heterochromatin components (Paredes and Maggert, 2009).  
  
The increased heterochromatic content induced by pRNA in ESCs and the 
consequent loss of pluripotency underscore the role of the open chromatin of 
ESCs and suggest that nucleolar chromatin is an important regulator of the 
pluripotent state. As the open chromatin of ESCs has been proposed to contribute 
to the developmental plasticity or pluripotency (Efroni et al., 2008; Gaspar-Maia et 
al., 2009; Melcer et al., 2012; Meshorer et al., 2006), remodelling into rigid 
heterochromatic structures has also to be considered as part of a cell program 
aimed to restrict chromatin plasticity, to influence defined gene expression profiles 
and to drive cells into specific lineages. Positioning of H3K9me3 rich regions and 
clustering of centromeres around nucleoli were previously described to 
accompany changes in nuclear architecture during ESC differentiation (Bartova et 
al., 2008a; Wiblin et al., 2005). Although we cannot pinpoint which is the first 
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event that starts remodelling of nuclear architecture toward a highly condensed 
heterochromatic form during differentiation, our results place the nucleolus as an 
important regulator of this process. First, the establishment of rDNA 
heterochromatin during differentiation coincides with the formation of highly 
condensed heterochromatic form such as maturation of centric and pericentric 
heterochromatin and formation of LOCKs (Meshorer and Misteli, 2006; Wen et al., 
2009). Second, we showed that targeting of heterochromatin at rDNA in ESCs 
induced heterochromatic changes similar to those found in somatic cells and 
leads to loss of pluripotency. Third, impairing the formation of rDNA 
heterochromatin by TIP5 knockdown inhibits ESC differentiation, suggesting that 
the establishment of nucleolar heterochromatin might be a necessary step for the 
switch from a lower to a higher order chromatin structure and exit from the 
undifferentiated state.   
In summary, our data underline the importance of chromatin structure in ESC 
pluripotency and differentiation potential and indicate that the epigenetic state of 
nucleolar chromatin is a key regulator of nuclear architecture and chromatin 
plasticity which serves to control cell pluripotency and commitment. 
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Figure 7. Model showing how the addition of pRNA to ESCs establishes nucleolar and 
nuclear heterochromatin while depletion of TIP5 impairs differentiation. The unprocessed 
IGS-rRNA transcript present in ESC impairs the association of TIP5 with TTF1, inhibiting 
recruitment to rDNA and formation of heterochromatin (middle panel). Addition of pRNA to ESCs, 
that allows TIP5 to interact with TTF1 and to be recruited to rDNA, is sufficient to establish 
nucleolar and nuclear heterochromatin like that one found in somatic cells and leads to loss of 
pluripotency (right panel). Tip5 depleted ESCs are impaired in differentiation probably due to their 
inability to form nucleolar heterochromatin (left panel). 
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